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ABSTRACT 
x 
The safe or no~-teratogenic levels following prenatal exposure of 
animals to chlorophenoxy herbicides are currently based on offspring 
survival, growth and absence of anatomical defects or overt neurolog-
ical impairment. No adequate consideration is given to possible sub-
tle neurological consequences. 
Pregnant rats were gavaged with 2 ml/kg/day of peanut oil vehicle 
(control, G1), 50 (G2), 100 (G3) and 125 (G4) mg/kg/dayof 1:1 2,4-D/ 
2,4,5-T mixture (as found in Agent Orange) on gestational days 6 to 15. 
Group 3 and 4 mothers gained significantly (P<0.05) less weight during 
pregnancy and delivered fewer offspring than control. Neonatal mortal-
ity on postnatal day (PND) 1 significantly increased only in G4. 
Treatments did not significantly affect gestational lengths, sex rati-
os or birth weights, and no anatomical defects were seen. With the 
exception of a significant 3% reduction in body weights of the progeny 
in G4 on PND 60, treatments did not affect progeny growth and matura-
tional landmarks of development. 
xi 
Surface righting (PND 2-5), negative geotaxis at 45 0 angle (PND 
15-17) and swimming performance (PND 7-21) were significantly delayed 
in all the treated groups. Olfactory discrimination of home-nest odor 
(PND 9-11) and negative geotaxis at 25 0 angle (PND 7-11) were signifi-
cantly delayed in 63 and 64. In the females of 62, the negative geo-
taxis response at 25 0 was significantly delayed on PND 9. Higher run-
ning wheel activity was seen only in the male progeny of 64 on PND 22 
and 23 and following d-amphetamine sulfate challenges. 
~ utero exposure to 2,4-D/2,4,5-T altered neurochemical develop-
ment of the progeny. In 62 and 64 glutamate contents in the cerebrum 
and cerebellum were ~ignificantly reduced on PND 1. 6ABA levels were 
unaffected by treatments. Examination of regional brain protein, DNA 
and RNA contents and protein:DNA and RNA:DNA ratios did not indicate 
severe of generalized developmental deficits. However, on PND 22 RNA 
levels in the neocortex of 64 and protein:DNA ratios (cell size) in 
the thalamus-hypothalamus of 62 and 64 were significantly reduced. 
Whole brain DA but not NE turnover of 62 and 63 was signficantly 
reduced on PND 3. Treatment (62 and 63) also delayed ontogeny of DA 
but not NE levels in the thalamus-hypothalamus, pons-medulla on PND 7, 
9 and 15 and olfactory bulb on PND 9. On PND 25 5-HT levels were sig-
nificantly reduced in pons-medulla of 63, whereas its metabolite 
5-HIAA levels decreased in thalamus-hypothalamus and pons-medulla of 
62 and 63. 
The data indicated that prenatal exposure to non-teratogenic 
levels of 2,4-D/2,4,5-T mixture produced adverse behavioral and neuro-
logical consequences in the overtly normally developing rat progeny 
lasting well past cessation of herbicides exposure. The neurochemical 
xii 
findings provided possible neurochemical basis for some of the 2,4-0/ 
2,4,5-T induced neurobehavioral effects. The data also indicated the 
values of behavioral and neurochemical ontogenic assessment of low 
dose exposures which result in functional alterations in the absence 
of overt toxic signs. 
1 
I. INTRODUCTION 
Chlorinated phenoxy herbicides 2,4-dichlorophenoxyacetic acid 
(2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) contaminated 
with 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) are important envi-
ronmental pollutants. The extensive usage of these herbicides have 
increased the awareness about their potential health hazards. 
The acute and chronic toxic effects as well as the occupational 
hazards of 2,4-D and 2,4,5-T or their 1:1 combination contaminated 
with TCDD (known as Agent Orange) have been well documented (Hayes, 
1982). However, ove~t neurological impairment is the clinical end-
point currently used to document a case of "Agent Orange" or other 
chlorophenoxy herbicides exposure in mammals. Adequate consideration 
is not given to possible subtle neurological consequences of such 
exposure. Although a large volume of toxicological data are available 
concerning 2,4-D and 2,4,5-T, there is a serious inadequacy of data on 
the more subtle effects. This represents a clear gap in our knowledge 
about these important environmental contaminants which in turn pre-
cludes any rapid or easy resolution of the issue in man. 
The fetotoxicity and teratogenicity of 2,4-D and 2,4,5-T have 
been thoroughly investigated and documented in several animal species 
(Schwetz et al., 1971; Collins and Williams, 1971; Khera and McKinley, 
o 1972; Bage et al., 1973; Courtney, 1977; Beck, 1981). However, 
limited and conflicting data are available on the developmental 
effects of the phenoxy herbicides in humans (Nelson et al, 1979; 
Hanifyet al., 1981; Smith et al., 1982; Thomas and Czeizel, 1982; 
Norman, 1983; Casey and Collie, 1984; Friedman, 1984). Although no 
2 
clear cut relation exists between prenatal exposure to 2,4-0 and 
2,4,5-T and the rate of miscarriages, fetal abnormalities, or matura-
tional delays, there are some indications that these herbicides are 
potentially hazardous to human fetuses (U.S~ EPA, 1979; Field and 
Kerr, 1979; Hanify et al., 1981; Norman, 1983; Casey and Collie, 
1984). 
One of the important toxicological issues of the phenoxy herbi-
cides is the concern over the effects of sub-teratogenic levels on 
neurobehavioral development of mammalian progeny following ~ utero 
exposure. It is obvious that structural effects alone (e.g. death, 
growth retardation and malformation) following prenatal exposure to 
non-teratogenic levels of 2,4-0 and 2,4,5-T are insufficient indicants 
of toxicity. The brain of the developing fetus is especially vulner-
able to insults induced by chemical agents that cross the immature 
blood brain barrier during the critical period of brain development. 
The phenoxy herbicides 2,4-0 and 2,4,5-T readily cross the placental 
barrier and distribute into various fetal organ tissues including the 
brain (Lindquist and Ullberg, 1971; Fang et al., 1973; Dencker, 1976; 
Courtneyet al., 1977; Koshakji et al., 1979). It is therefore poss-
ible that the phenoxy herbicides at sub-teratogenic levels can induce 
a wide spectrum of subtle biochemical abnormalities which could be 
manifested during postnatal development as behavioral or functional 
abnormalities. 
Neurobehavioral developmental studies have shown that 2,4,5-T at 
sub-teratogenic levels is a behavioral teratogen in rats (Sjoden and 
Soderberg, 1972; 1975; 1978; Crampton and Rogers, 1983) and chickens 
(Sanderson and Rogers, 1981). However, the effects on development, 
3 
neurochemical and neurobehavioral-teratogenicity of non-teratogenic 
(non-malforming) levels of 1:1 mixture of 2,4-D and 2,4,5-T are not 
known in the mammalian progeny. Therefore, the purpose of this study 
was to use a multidisciplinary approach to evaluate in rats the 
effects of a 1:1 mixture of 2,4-D and 2,4,5-T on maturation, growth, 
neurochemical and neurobehavioral development following in utero expo-
sure to the compounds. The specific aims of this study were as fol-
lows: (1) to test the hypothesis that prenatal exposure of rats to 
non-teratogenic levels of 2,4-D/2,4,5-T mixtures results in subtle 
neurotoxic effects which will be manifested during postnatal develop-
ment as behavioral and neurochemical abnormalities; (2) to evaluate 
the effects of 2,4-D/ 2,4,5-T mixture on postnatal growth and matura-
tion; and (3) to apply, in a correlative manner when possible, a bat-
tery of tests to evaluate behavioral and neurochemical development of 
the progeny. 
The behavioral measurements used in this study (surface righting 
reflex, negative geotaxis, swimming performance, olfactory discrimin-
ation of home-nest odor and running wheel activity) are proven stan-
dard methods used to detect behavioral teratogens in rodents, and to 
evaluate the development of neuromuscular and CNS responses (Fox, 
1965; Altman and Sudarshan, 1975; Vorhees et al., 1979a,b; Adams and 
Buelke-Sam, 1981; Comer and Norton, 1982). The ontogeny of whole 
brain catecholamine (CA) turnover was determined. The levels of norep-
inephrine (NE), dopamine (DA), serotonin (5-HT) and its metabolite 
5-hydroxyindoleacetic acid (5-HIAA), r-aminobutyric acid (GABA), gluta-
mate, protein, DNA and RNA in discrete brain areas of the developing 
progeny were also determined. Brain biogenic amines, GABA and gluta-
mate have been implicated as mediators and/or modulators of CNS func-
4 
tion as well as neuromuscular activity (Jacobs, 1976; Mabry and 
Campbell, 1977; Anden et al., 1979; Roberts and Anderson, 1979; 
Bartholini, 1980; Gerson and Baldessarini, 1980; Tam~sy et al., 1981; 
McGeer and McGeer, 1981; Adams and Buelke-Sam, 1981; Olson and Morgan, 
1982; Donzanti and Uretsky, 1983; Fuller, 1983; Bannon and Roth, 1983). 
Brain proteins and nucleic acids have been used as biochemical markers 
of brain maturation during postnatal development (Geel and Timiras, 
1967; Winick, 1976; Gombos et al., 1980; Mahler, 1981; Benjamins and 
McKhann, 1981; Dunlop et al., 1984). 
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II. LITERATURE REVIEW 
CHLORINATED PHENOXY HERBICIDES 
Introduction 
The chlorinated phenoxy compounds are widely used herbicides. 
They act as auxins* to regulate plant growth. Higher concentrations 
of the phenoxy herbicides induce abnormal plant growth, disturb the 
normal regulatory mechanisms of the endogenous auxins, interfere with 
o 
the transport of nutrients, and eventually destroy the plant (Aberg 
and Eliasson, 1978, ~ayes, 1982). The extensive use of phenoxy herbi-
cides has increasingly resulted in considerable concerns about their 
health hazards to humans and animals. 
2,4-0 and 2,4,5-T are the most important phenoxy herbicides used. 
Agent Orange, which consists of a 1:1 mixture of n-butyl esters of 
2,4-0 and 2,4,5-T and TCDD as a contaminant, was extensively used as a 
defoliant for military purposes in Asia. 
* The growth and development of plants are regulated by a number of 
low molecular weight organic compounds known as plant hormones, the 
o 
most important of which are auxins, gibberellins and cytokinins (Aberg 
and Eliasson, 1978). 
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2,4-0 
Chemical and Physical Properties 
The chemical and physical properties of 2,4-0 have been ade-
quately described (IARC, 1977a; Weed Sci. Soc., 1979; Hayes, 1982). 
2,4-0 has a molecular weight of 221.04, and the following structure: 
It is a white crystal powder, odorless or with a slight phenolic 
odor. Its melting point is between 140-141°C, and the boiling point 
is 160°C at 0.4 mm. The solubility of 2,4-0 in water is 620 mg/L at 
25°C. 2,4-0 is soluble in alcohols, acetone, dioxane and aqueous alka-
li, but is essentially insoluble in petroleum oils. 
Production and Use 
2,4-0 is industrially prepared by two chemical reactions (Rappe, 
1978a). The initial reaction involves the chlorination of the phenol 
or ,0-creso1, followed by acetylation with c~roacetic acid and sodium 
hydroxide to form 2,4-0: 
OH 
@ :> 
OH 
r6/_1_C_l_CH_2C_0_OH---=>~ 
~. NaOH 
Cl 
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The free acid form of 2,4-0 is seldom used as a herbicide (Rappe, 
1978a). The esters and salts of 2,4-0 are commonly used as herbicides 
either alone or in combination with other herbicides (Table 1). 2,4-0 
is a systemic herbicide used to control broad leaf weeds (Weed Sci. 
Soc., 1979), and to control the ripening process of bananas and citrus 
fruits. The compound is also used as a fungicide during lemon storage 
(WHO, 1975). About 27 million kg of 2,4-0 were used in the USA in 
1975 (lARe, 1977a). 
Absorption and Fate 
. 
2,4-0 and its esters or salts were readily absorbed from the gas-
trointestinal tract, and widely distributed in the animal body (Erne, 
1966a,b; Leng, 1977; Gehring and Betso, 1978). Dermal absorption of 
2,4-0 was relatively low. When 2,4-0 was applied to the forearm of 
human volunteers only 5.8% of the dose was absorbed and excreted in 
the urine (Feldmann and Miabach, 1974). The rate of absorption, how-
ever, was increased to 14.7% by covering the application site with a 
plastic film for 24 hours after dosing (Feldmann and Maibach, 1974). 
When 2,4-0 was administered intratracheally to rats, 50% of the dose 
was absorbed, presumably by diffusion across the alveolar membranes 
(Burton et al, 1974). 
Plasma levels of administered 2,4-0 peaked within 2 to 4 hours of 
administration depending on the animal species, dose and the route of 
administration (Erne, 1966a; Sauerhoff et al., 1976a; Leng, 1977). 
2,4-0 administered to different animal species (mouse, rat, pig, 
sheep, cattle, dog and chicken) was distributed into various tissues 
and was found in high concentrations in the plasma, liver, lungs, 
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TABLE 1: TRADE NAMES OF COMMERCIAL PRODUCTS CONTAINING 
2,4-0 AND 2,4,5-T* 
2,4-0 
Weedar 64 
Rhodia 2,4-0 
Amine No. 4 
OMA-4 
Weed-Rhap A-40 
Amine 4-0 
Emulsamine E-3 
Weedone LV-4 
Weedone 638 
Rhodia 2,4-0 Low 
Volatile Ester 4L 
Esteron 99 Conc. 
Esteron 76 BE 
Esteron 6E 
Weed-Rhap LV 40 
BP LO-VOL 40 
Butyl 40 
Butyl 60 
Abco W.K.-67 2,4-0 
Weed Killer 
2,4,5-T 
Weedar 
Weedone 
Amine 4T 
Oecamine 4T 
LO-VOL 4T 
VEON 245 
Esteron 245 
Brush-Rhap A-4T 
Brush-Rhap LV-
OX Y-4T 
Abco Improved 
W.K.-245 
* (IARC, 1977a,b; Weed Sci. Soc., 1979). 
2,4-0 + 2,4,5-T 
Oacamine 
Abco W. K. -OT 133 
Acme Poison Ivy Killer 
Acme Weed-No-More-Spotter 
Agent Orange 
Agent Purple 
Some of these products are no longer manufactured. 
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brain and urine (Erne, 1966a,b; Leng, 1977; Elo and Ylitalo, 1977; 
1979; Gehring and Betso, 1978; Orberg, 1980). Intracellular distri-
bution studies showed that 2,4-0 was localized in the soluble fraction 
of cells, nuclear, mitochondrial and microsomal fractions (Khanna and 
Fang, 1966). 2,4-0 was also found to bind reversibly to plasma pro-
teins, especially albumin (Erne, 1966b; Haque et al., 1975; Gehring 
and Betso, 1978; Orberg, 1980). The levels of 2,4-0 in the brains of 
rats, pigs and chickens were relatively low (1.5 to 15.3% of the plas-
ma or blood levels) at subtoxic doses (Erne, 1966a; Khanna and Fang, 
1966). At a high toxic dose (250 mg/kg), however, 2,4-0 levels in the 
brain and CSF of the ~ at increased by 11- to 39-fold, respectively 
(Elo and Ylitalo, 1977; 1979). ~ vitro uptake studies with rabbit 
choroid plexus showed that 2,4-0 was transported by an organic anion 
energy dependent mechanism (Pritchard, 1980). The same uptake mechan-
ism was responsible for its transportation from the CSF (Kim et al., 
1983). 
Distribution studies in pregnant animals showed that 2,4-0 
crossed the placental barrier (Bjorklund and Erne, 1966; Lindquist and 
Ullberg, 1971; IARC, 1977a). Within 24 hours after administration of 
2,4-0 to pregnant rats, about 17% of the dose was detected in the uter-
us, placenta, fetus and amniotic fluid (IARC, 1977a). Lindquist and 
Ullberg (1971) also reported that after intravenous injection of 2,4-0 
to pregnant mice the compound accumulated in the visceral yolk sac and 
passed to the fetal tissues. 
The esters of 2,4-0 were found to be rapidly metabolized in the 
body to the acid form (Erne, 1966b; Leng, 1977). The acid form of 
2,4-0 did not undergo major biotransformation, and was excreted mainly 
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unchanged in the urine (Khanna and Fang, 1966; Shafik et al., 1971; 
Sauerhoff et al., 1977; Leng, 1977; Gehring and Betso, 1978). Minor 
quantities of 2,4-0, however, were conjugated with glycine, taurine 
and glucuronic acid (Erne, 1966b; Sauerhoff et al., 1977; Leng, 1977). 
Small amounts of the oral dose of 2,4-0 were reported to be excreted 
in the feces (Leng, 1977). Traces of administered 2,4-0 occurred in 
the milk of lactating animals (IARC, 1977a; Leng, 1977). 
The plasma half lives of 2,4-0 in different animal species are 
presented in table 2. Apparently the elimination rate of the compound 
varied among different animal species. The elimination rate of 2,4-0, 
however, appeared to be a dose dependent process (Leng, 1977). Shafik 
and coworkers (1971) reported that the total amount of 2,4-0 excreted 
by the rat decreased as the dosage was increased. This phenomenon 
suggested that the renal excretory sites were saturated. In pigs and 
chickens, however, an increased elimination rate of 2,4-0 was observed 
after repeated oral administration of the compound in amounts insuffi-
cient to saturate the active transport mechanisms in the kidney (Erne, 
1966a). 
Toxicity 
Human studies: Human exposure to 2,4-0 and other phenoxy herbicides 
have occurred through manufacturing processes, application processes, 
drifts, ingestion of contaminated water, soil, vegetables, fruits and 
dermal contact while handling the chemical or contaminated equipment 
(IARC, 1977a,b; Stevens, 1981; Hayes, 1982; Kolmodin-Hedman et al., 
1983). 
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TABLE 2: THE REPORTED PLASMA HALF-LIFE OF 2,4-0 IN MAN AND ANIMALS 
Species Dose Route tHhr) Reference 
Man 5 mg/kg oral 33 Kohli et al., 1974 
Man 5 mg/kg oral 11.6 Sauerhoff et al., 1977 
Man 400 mg/kg oral 16.7 Young and Haley, 1977 
Man 70 ml of 
10% solution oral 219 Park et al., 1977 
Rat 100 mg/kg oral 2.9-6 Erne, 1966a 
Pig 100 mg/kg oral 10-12 Erne, 1966a 
Calf 100 mg/kg oral 7.5-10 Erne, 1966a 
Chicken 100 mg/kg oral 7.7 Erne, 1966a 
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The reported symptoms of 2,4-0 in humans were nausea, vomiting, 
headaches, general weakness, poor appetite, abdominal pains, insomnia, 
tremors, muscle hypotonia, hypotention and cardiac arrhythmias 
(Tsapko, 1966; Fetisov, 1966; Berwick, 1970; Prescott, 1979; Wells et 
al., 1981; Pond et al., 1982; Hayes, 1982). Symptoms of chronic expo-
sure to 2,4-0 included skin irritation, eczema, hypersensitivity reac-
tion, general weakness, poor appetite, peripheral neuropathy and liver 
dysfunction (Goldstein et al., 1959; Todd, 1962; Berkley and Magee, 
1963; IARC, 1977a; Gehring and Betso, 1978; Hayes, 1982; Singer et 
al., 1982). 
Animal studies: The acute L050 va1ues for 2,4-0 in different animal 
species are presented in table 3. 2,4-0 is considered to be moder-
ately toxic to laboratory animals. The reported toxic symptoms associ-
ated with 2,4-0 poisoning in animals were myotonia, ataxia, paralysis, 
muscular weakness, decreased body temperature, reduced metabolic rate, 
loss of appetite, progressive weight loss, vomiting, gastrointestinal 
disturbances, depression and roughness of hair-coat (Hill and 
Carlisle, 1947; Orill and Hiratzka, 1953; Rowe and Hymas, 1954; 
Bjorklund and Erne, 1966). The cause of death in laboratory animals 
was thought to be due to ventricular fibrillation (Hayes, 1982). 
Among the domestic animals, the pig and dog were highly sensitive 
to 2,4-0 toxicosis; whereas chickens showed the lowest sensitivity 
(Bjorklund and Erne, 1966). Monkeys tolerated 214 mg/kg of 2,4-0 oral-
ly without serious effects (Hill and Carlisle, 1947). Oermal toxicity 
of 2,4-0 was relatively low in monkeys, and skin irritation or sys-
temic effects were not observed (Kay et al., 1965). 
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TABLE 3: THE REPORTED ACUTE LD50 VALUES FOR 2,4-0 IN ANIMALS 
LD50 
Species (mg/kg) Route Reference 
Mouse 375 oral Hill and Carlisle, 1947 
Mouse (M) 368 oral Rowe and Hymas, 1954 
Rat 666 oral Hi 11 and Carlisle, 1947 
Rat (M) 375 oral Rowe and Hymas, 1954 
Rat (M) 395 oral Gaines, 1978 (cited by Hayes, 1982) 
Rat (F) 390 oral Gaines, 1978 (cited by Hayes, 1982) 
Rat (M) 443 oral Squibb et al., 1983 
Rat (M) >2000 'dermal Gaines, 1978 (cited by Hayes, 1982) 
Rat (F) >2000 derma 1 Gaines, 1978 ( cited by Hayes, 1982) 
Guinea pig 1000 oral Hi 11 and Carlisle, 1947 
Guinea pig 469 oral Rowe and Hymas, 1954 
Chicken 541 oral Rowe and Hymas, 1954 
Rabbit 800 oral Hi 11 and Carlisle, 1947 
Dog 100 oral Drill and Hiratzka, 1953 
M = male, F = female 
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One of the currently important toxicological concerns associated 
with 2,4-0 exposure is the neurotoxic and behavioral effects of low 
level exposure. The neurotoxicity of phenoxy herbicides reported in 
man can be divided into peripheral neuropathies and central disorders 
(Goldstein, 1959; Berkley and Magee, 1963; Wallis et al., 1970; Kontek 
et al., 1973; Singer et al., 1982). Changes in the peripheral nerve 
fibers included slow conduction velocities (Goldstein, 1959; Nielsen 
et al., 1965; Wallis et al., 1970; Singer et al., 1982). On biopsy 
examination, degenerative changes were seen in the peripheral nerve 
fibers (Wallis et al., 1970). Kontek and coworkers (1973) reported 
abnormal electroencephalogram (EEG) patterns in farmers who had been 
. 
spraying 2,4-0. However, abnormal EEG patterns were not seen in one 
patient exposed to 2,4-0 (Berkley and Magee, 1963). In one study, 
degenerative changes in the ganglionic cell of the pons were seen in a 
patient who died following 2,4-0 exposure (Nielsen et al., 1965). 
Animal studies have provided additional support for the involve-
ment of the CNS in 2,4-0 neurotoxicity. Pharmacokinetic studies indi-
cated high concentrations of 2,4-0 in brains and CSF of treated rats 
(Elo and Ylitalo, 1977; 1979). The possibility that 2,4-0 damaged the 
blood brain barrier was suggested from subsequent studies (Elo et al., 
1982; Hervonen et al., 1982). Altered brain EEG was also reported in 
rats exposed acutely or subacutely to 2,4-0 (Oesi et al., 1962a,b; 
Hayes, 1982). Histological examination of the spinal cord of 2,4-0 
treated rats revealed regions of demyelination of the pyramidal tract 
(Oesi et al, 1962a). 
Surely neurochemical lesions must have preceded anatomical le-
sions. There is increasing interest among both researchers and laymen 
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in the subtle effects of Agent Orange partly from the realization that 
structural effects alone, e.g. death, malformation at birth and growth 
retardation, are not sufficient indicators of the toxic effects of 
environmental pollutants. Rats treated with 2,4-0 manifested loss of 
the previously learned condition reflex (Desi et al., 1962a,b). 
Squibb and coworkers (1983) reported increased fore and hind limb grip 
strength in rats orally treated with 20 to 80 mg/kg of 2,4-0 twice a 
week for 5 weeks. The reported neurological effect, however, was 
found to dissipate with time following cessation of 2,4-0 dosing 
(Squibb et al., 1983). In contrast, other neurological measurements 
(negative geotaxis, hin~ limb splay, spontaneous motor activity and 
startle responses) were not affected (Squibb et al., 1983). 
Effects on Reproduction 
Animal studies: Table 4 summarizes the observed fetotoxic and terato-
genic effects of 2,4-0 in different animal species. The teratogenic 
effects appeared to be species and dose-dependent. The observed abnor-
malities, however, varied qualitatively and quantitatively from one 
animal species to another (Table 4). Oral exposure of rats to 87.5 
mg/kg of 2,4-0 on gestational days 6 to 15 produced fetal abnormal-
ities of decreased body weight, delayed skeletal ossification, subcu-
taneous edema, lumbar ribs and wavy ribs (Schwetz et al., 1971). The 
authors, however, did not consider these abnormalities as teratogenic 
indicants, since the viability, neonatal growth and development were 
not affected (Schwetz et al., 1971). Teratogenic effects of 2,4-0, 
however, were reported in rats, mice and birds (Khera and McKinely, 
1972; Lutz and Lutz-Ostertag, 1972; 1973; Courtney, 1977). In the 
TABLE 4: FETOTOXIC AND TERATOGENIC EFFECTS OF 2,4-0 IN MAMMALS 
Gestational 
Daily oral exposure Maternal 
Species dose (days) toxicity Fetotoxicity Teratogen i c ity Reference 
Rat 87.5 mg/kg 6-15 decreased Schwetz et al., 1971 
body weight, 
subcutaneous 
edema, 
delayed bone 
ossification. 
Rat 100-150 mg/kg 6-15 decreased skeletal Khera and McKinley, 1972 
body weight defects. 
Mouse 1 mM/kg 12-15 weight decreased cleft palate Courtney, 1977 
loss body weight 
Hamster 100 mg/kg 6-10 fetal death Collins and Will i ams, 1971 
- -
no effect observed. 
..... 
0'1 
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hamster, 9 to 10% decrease in fetal viability per litter was reported 
(Collins and Williams, 1971). This effect was not dose dependent and 
no malformation or decreased fetal growth were observed, except the 
occasional cases (0.8 to 4%) of fused ribs in some of the 2,4-0 ex-
posed fetuses (Collins and Williams, 1971). Similarly no congenital 
malformations were seen in lambs prenatally exposed to 2 g of 2,4-0 
daily during the first 30, 60 or 90 days of gestation (Binns and 
Johnson, 1970). In a 3-generation reproduction study of rats, dietary 
levels of 2,4-0 at 100 and 500 ppm did not produce adverse effects 
(Hansen et al., 1971). At 1500 ppm, 2,4-0 did not affect the fertil-
ity of either sex or litter size, but sharply reduced the survival of 
the pups to weaning and the weights of the weanlings (Hansen et al., 
1971). In another study, rats were given 2,4-0 at 1000 mg/L in the 
drinking water throughout pregnancy and for an additional 10 months 
(Bjorklund and Erne, 1966). No adverse effects were observed on pro-
geny, parturition and litter size. No malformation occurred in the 
fetuses. After weaning, 2,4-0 was then administered to the offspring 
for up to 2 years. This treatment resulted in a significant growth 
retardation and decreased postnatal survival. 
A pregnant sow ingested 2,4-0 (500 mg/kg of diet) and gave birth 
to one mumified fetus and 15 underdeveloped piglets (Bjorklund and 
Erne, 1966). Ten of the piglets died within 24 hours of parturition. 
Ouffard and coworkers (1982) reported no fetotoxic effects in 
hatching chicks following painting of the eggs before incubation with 
2,4-0 at 0.8 to 12.1 mg/kg. Biochemical brain lesions observed in the 
hatched chicks included increased protein, lipid and gangliosides, and 
decreased cholesterol and glycolipids. 
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In an ~ vitro study 2,4-0 inhibited the growth and multiplica-
tion of Earle's L cells (mouse fibroblasts) in the culture medium 
(Kolberg et al., 1970). This effect was reversible following removal 
of 2,4-0 from the ~ vitro system. Thus, the growth retardation and 
teratogenic effect seen ~ vivo may be due to a direct action of 2,4-0 
on fetal cells. 
It is obvious from the reproductive outcome studies cited above 
that structural effects (e.g. death, growth retardation and malforma-
tion) following prenatal exposure to non-teretogenic levels of 2,4-0 
are insufficient indicants of toxicity. In the rat, for example, 
levels of 2,4-0 up to 87,5 mg/kg (Table 5) were considered to be non-
teratogenic. It is interesting that although much is known about the 
acute toxic effects of 2,4-0 in mammals, the neurobehavioral and neuro-
chemical effects of prenatal exposure of mammals to sub-teratogenic 
and sub-fetotoxic levels of 2,4-0 are not known. 
Human studies: Recently, Casey and Collie (1984) reported severe men-
tal retardation and physical abnormalities in a 2-year old girl whose 
parents were exposed to 2,4-0 sprays for 6 months prior to conception 
and until pregnancy was confirmed 5 weeks after the mother's last men-
strual period. The spray occurred 6 days a week, approximately 7 
hours a day. 
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TABLE 5: NON-TERATOGENIC LEVELS OF 2,4-D IN RATS 
Gestational 
Oral dose exposure (days) Reference 
100 & 500 ppm in diet all Hansen et al., 1971 
up to 87.5 mg/kg 6-15 Schwetz et al., 1971 
25 & 50 mg/kg 6-15 Khera and McKinley, 1972 
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2,4,5-T 
Chemical and Physical Properties 
The chemical and physical properties of 2,4,5-T have been ade-
quately described (IARC, 1977b; Weed Sci. Soc., 1979; Hayes, 1982). 
2,4,5-T has a molecular weight of 255.49 and the following structure: 
&:~H 
Cl~ 
Cl 
It is a white crystal powder with a melting point between 150-
158°C and a solubility in water of 238 mg/L at 50°C. It is soluble in 
alcohols but not in petroleum oils. 
Production and Use 
2,4,5-T is produced industrially following the alkaline hydrol-
ysis of 1,2,4,5-tetrachlorobenzene to 2,4,5-trichlorophenol (TCP) and 
a subsequent reaction with chloroacetic acid: 
Cl~l __ -..:>;;.Cl«H C1CH2COOH > 
Cl ~Cl Cl Cl NaOH 
TCDD is formed as a stable by-product or contaminant during the 
production of TCP. This uncontrolled reaction takes place when the 
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alkaline reaction mixture is heated to 230-260°C at about 50 atmos-
pheric pressure (Rappe, 1978b): 
NaOH 
+ 
Cl ~_l _M_e_OH--:o::--_---':>:.C1 'rQYoNa H ';1 'rQY0H ~,,180C ~ ~ C1 C1 50 atm. C1 C1 C1 C1 
t30 C;l§()§tCl 
C1 C1 
(TCDD) 
The 2,4,5-T produced prior to 1965 contained 30 ppm or more TeDD 
(IARC, 1977b). On subsequent years contamination with TeDD was 
reduced to as low as 0.02-0.05 ppm (IARe, 1977b). 
The esters and salts of 2,4,5-T, either alone or in combination 
with other herbicides, are commonly used as herbicides (Table 1). 
2,4,5-T is used as a systemic herbicide, and is especially effective 
on woody and herbaceous weeds. Its 1:1 mixture with 2,4-0 (Agent 
Orange) was used to defoliate jungle areas in Vietnam. An estimated 3 
million kg of 2,4,5-T were used in the USA in 1975 (IARC, 1977b). 
Absorption and Fate 
2,4,5-T and its salts or esters were readily absorbed from the 
gastrointestinal tract of different animal species and became widely 
distributed in the body (Leng, 1977; Gehring and Betso, 1978). Rapid 
pulmonary absorption (50%) of 2,4,5-T was reported in rats following 
intratracheal administration of the compound (Burton et al., 1974). 
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The peak plasma concentration and volume of distribution (Vd) 
of 2,4,5-T were found to be dose-dependent (Piper et al., 1973; 
Gehring et al., 1973; Leng, 1977; Gehring and Betso, 1978). Depending 
on the animal species and the dosage given, the plasma levels of the 
orally administered 2,4,5-T peaked in 4 to 24 hours post-administra-
tion (Piper et al., 1973; Gehring et al., 1973; Leng, 1977; Gehring 
and Betso, 1978). The peak plasma concentration of 2,4,5-T was lower 
in rats and dogs than in humans, whereas the Vd of 2,4,5-T was higher 
in rats and dogs than in humans (Piper et al., 1973; Gehring et al., 
1973). The highest tissue concentration of 2,4,5-T was in the plasma 
and kidneys of rats and humans (Fang et al, 1973; Leng, 1977). 
2,4,5-T was found to extensively bind to plasma proteins (Gehring et 
al., 1973; Haque et al., 1975; Mason, 1975; Koschier et al., 1979). 
The binding of 2,4,5-T to renal microsomes was associated with high 
levels of 2,4,5-T in renal tissues (Koschier et al., 1979). 
The reported plasma half lives of 2,4,5-T in different species 
were variable and dose dependent (Table 6). A 5.3-fold increase in 
the plasma elimination t; of 2,4,5-T in the rat occurred when the oral 
or intravenous dose was increased from 5 mg/kg to 100 or 200 mg/kg and 
was indicative that the excretory capacity of the animal was exceeded 
(Piper et al., 1973; Sauerhoff et al., 1976b). 
2,4,5-T crossed the placental membranes of the pregnant mouse and 
rat, and distributed into the fetal organs (Lindquist and Ullberg, 
1971; Fang et al., 1973; Dencker, 1976; Courtneyet al., 1977; 
Koshakji et al., 1979). Administration of 2,4,5-T on day 13 of gesta-
tion resulted in significant herbicide levels in the fetal mouse 
23 
TABLE 6: THE REPORTED PLASMA HALF-LIFE OF 2,4,5-T IN MAN AND ANIMALS 
Dose tl 
Species (mg/kg) Route (hr) Reference 
Man 5 oral 23.1 Gehring et al., 1973 
Rat 5 oral 4.7 Piper et al., 1973 
50 oral 4.2 
100 oral 19.4 
200 oral 25.4 
Rat 5 1. v. 4.3 Sauerhoff et al., 1976b 
100 Lv. 23.1 
Dog 5 oral 77 Piper et al., 1973 
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within 30 minutes (Courtney et al., 1977). High levels of 2,4,5-T 
were seen in the fetal liver, skin, eyes and the brain (Lindquist and 
Ullberg, 1971; Fang et al., 1973; Dencker, 1976; Courtneyet al., 
1977). However, 2,4,5-T given to pregnant mice during early pregnancy 
(day 8 to 11) did not attain significant tissue levels in the fetus 
(Lindquist and Ullberg, 1971; Dencker, 1976). Similar findings were 
also reported when 2,4,5-T was administered to the hamster on gesta-
tion days 8 to 11 (Dencker, 1976). Thus significant transplacental 
crossing of 2,4,5-T occurred in the mouse only after day 11 or 12 of 
pregnancy (Dencker, 1976). In contrast, transplacental crossing and 
fetal distribution of 2,4,5-T did not occur in the guinea pig presum-
ably because of the high maternal excretion rate of the compound 
(Ebron and Courtney, 1976). 
Biotransformation of 2,4,5-T has not been extensive in animals. 
In rats and mice minor quantities of 2,4,5-T were converted to glycine 
and taurine conjugates as well as 2,4,5-trichlorophenol (Grunow et 
al., 1971; Shafik et al., 1971; Grunow and Boehme, 1974). Up to 85% 
of the administered dose of 2,4,5-T was recovered unchanged in the 
urine (Grunowet al., 1971; Piper et al., 1973; Fang et al., 1973). 
2,4,5-T underwent enterohepatic circulation which markedly affected 
its pharmacodynamic properties by prolonging the half-life of the com-
pound (Colburn, 1978; Eaton, 1982). 
2,4,5-T was primarily excreted in the urine as the unchanged acid 
and to a lesser extent as conjugated metabolites (Grunowet al., 1971; 
Grunow and Boehme, 1974; Leng, 1977; Gehring and Betso, 1978). The 
urinary excretion of 2,4,5-T was by an active process in the renal 
tubules which was saturable at higher concentrations of the compound 
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(Hook et al., 1974; 1976; Koschier and Berndt, 1977; Koschier and 
Acara, 1979). Studies with isolated perfused rat kidney demonstrated 
that a small dose of 2,4,5-T was efficiently excreted by the kidney 
(Koschier and Acara, 1979). Larger doses of 2,4,5-T, however, ex-
ceeded the excretory capacity of the kidney and markedly affected glo-
merular filtration, electrolyte transport and urine flow (Koschier and 
Acara, 1979). 
A small part of the administered 2,4,5-T was excreted in the fe-
ces (Piper et al., 1973; Leng, 1977). No radioactive C02 was detected 
in the expired air in rats given an oral dose of 14C-2,4,5-T, indi-
. 
cating that the compound was not eliminated by the lungs (Fang et al., 
1973). 
Toxicity 
Human studies: Similar to 2,4-0, humans may be exposed to 2,4,5-T 
through manufacturing and application processes, drifts, ingestion of 
contaminated water, soil, vegetables, fruits and most commonly through 
dermal contact while handling the chemical or contaminated equipment 
(IARC, 1977b; Newton and Norris, 1981; Stevens, 1981). 
The symptoms associated with 2,4,5-T toxicosis included muscular 
pain, fatigue, nervousness and intolerance to cold, liver disorders, 
neurological disorders and altered lipid metabolism (IARC, 1977b; 
Firestone, 1978). In a case of attempted suicide, a patient who drank 
a large quantity of a mixture of one third 2,4-0, one third 2,4,5-T 
butyl ester, and one third inert ingredients, manifested drowsiness, 
vomiting, heavy respiration, decreased blood pressure, fever and a 
sluggish response to painful stimuli (Hayes, 1982). 
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One of the most common symptoms associated with 2,4,5-T exposure 
(especially the dermal exposure) has been chloracne and other skin 
lesions. Firestone (1978) reported an outbreak of chloracne among 
2,4,5-T factory workers. Hirsutism, hyperpigmentation, increased skin 
fragility and vesicobu110us eruptions on the exposed parts of the skin 
were frequently observed among occupational workers exposed to 2,4,5-T 
(B1eiberg et a1., 1964; IARe, 1977b; Firestone, 1978). It has not 
been determined whether these skin lesions were due to 2,4,5-T or the 
TeDD contaminant. The skin disorders, however, were reported to be 
essentially associated with the TeDD contaminants found in 2,4,5-T 
(IARe, 1977b; Firestone, 1978; Flowers et a1., 1981). 
Health studies on humans exposed to Agent Orange yielded mixed 
results (Bogen, 1979; Fink, 1980; Korgeski and Leon, 1983). In a ten-
month study of veterans exposed to Agent Orange the clinical findings 
consisted of skin rashes, joint pain, stiffness and swelling, hypersom-
no1ence, fatigue, sinus bradycardia, premature ventricular contrac-
tions and gastrointestinal disorders (Bogen, 1979). The neurological 
complaints of patients were tingling, numbness, dizziness, headache 
and autonomic dyscontro1 (Bogen, 1979). Depression, suicidal at-
tempts, violent rages, inability to concentrate, sudden lapses of mem-
ory and loss of libido were also noted in the patients. The credibil-
ity of these findings were questioned, beacuse the degree of exposure 
to Agent Orange was unknown, the sampling procedures were not stated 
and appropriate control groups were not used (Fink, 1980; Weigand, 
1980). In a more recent study, Korgeski and Leon (1983) compared the 
neuropsychological and other health related parameters of patients 
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exposed to Agent Orange with appropriate human controls and found no 
statistical differences. 
Animal studies: The acute LD50 values for 2,4,5-T in different animal 
species are presented in Table 7. 2,4,5-T was considered to be moder-
ately toxic to animals (Bjorklund and Erne, 1966; Hayes, 1982). Symp-
toms of 2,4,5-T poisoning in animals included muscular weakness, atax-
ia, vomiting, diarrhea, weight loss and depression (Drill and 
Hiratzka, 1953; Rowe and Hymas, 1954; Dalgaard-Mikkelsen and Poulsen, 
1962). Drill and Hiratzka (1953) reported that dogs were highly sus-
" ceptible to 2,4,5-T toxicosis. A dose of 20 mg/kg/day of 2,4,5-T for 
5 days or more was fatal to dogs. In contrast, rats and chickens were 
more resistant to 2,4,5-T toxicosis (Whitehead and Pettigrew, 1972; 
Chang et al., 1974; Table 7). 
The available data about the neurotoxic and behavioral effects of 
2,4,5-T in mammals are limited in scope and numbers. Sjoden and 
Archer (1977) reported that rats treated with 2,4,5-T developed a con-
ditioned saccharin taste aversion. Neurochemical studies in rats 
treated with 2,4,5-T revealed a marked elevation in brain tryptophan 
and 5-hydroxyindoleacetic acid levels (Sjoden and Soderberg, 1978). 
The serious inadequacy of data on the neurological effects of 2,4,5-T 
represents a significant gap in our knowledge of 2,4,5-T induced toxi-
cosis in mammals. 
Effects on Reproduction 
Animal studies: 2,4,5-T produced a wide range of fetotoxic and terato-
genic effects in different animal species (Lutz and Lutz-Ostertag, 
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TABLE 7: ACUTE ORAL LD50 VALUES FOR 2,4,5-T IN ANIMALS 
Species LD50 (mg/kg) Reference 
Mouse (M) 389 Rowe and Hymas, 1954 
Rat (M) 500 Rowe and Hyams, 1954 
Guinea pig 381 Rowe and Hymas, 1954 
Dog >100 Drill and Hiratzka, 1953 
Chicken 310 Rowe and Hymas, 1954 
Mallard duck >2000 Kenaga, 1975 
M = male 
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1972; 1973; Table 8). The effects varied not only from one species to 
another but between different strains of mice (Gaines et al., 1975). 
The contribution of the contaminant TCDD in 2,4,5-T induced feto-
toxic and teratogenic effects has not been elucidated. Earlier terato-
genic studies indicated that 2,4,5-T containing as much as 30 ppm of 
TCDD was fetocidal in mice and produced cleft palate and cystic kidney 
(Courtneyet al., 1970). In subsequent studies in mice, Courtney and 
Moore (1971) reported that technical grade of 2,4,5-T containing 0.5 
ppm of TCDD also produced cleft palate and kidney malformation. How-
ever, even the analytical grade of 2,4,5-T containing less than 0.05 
ppm of TCDD was found to be teratogenic in mice (Courtney and Moore, 
1971). Similar teratogenic effects were seen with TCDD alone at doses 
as low as 0.001 mg/kg/day. No potentiation of the teratogenic effects 
was observed when the analytical grade of 2,4,5-T (100 mg/kg) and TCDD 
(0.001 mg/kg) were given to mice on gestational days 6 to 15 (Courtney 
and Moore, 1971). However, more than 1.5 ppm of TCDD were required to 
potentiate the teratogenic effects of 30 to 60 mg/kg of 2,4,5-T in 
mice (Neubert and Dillmann, 1972). 
2,4,5-T produced several teratogenic effects in different strains 
of mice (Table 8). Cleft palate was the most frequently observed tera-
togenic finding associated with 2,4,5-T administration to pregnant 
mice around day 11 of gestation (Hood et al., 1979). This period cor-
responds to the time of palate closure (Pratt, 1983). Other terato-
genic effects in mice included skeletal and kidney abnormalities in 
addition to nonspecific morphological changes (Table 8). Highman and 
coworkers (1977) also reported a delay in the development of renal 
alkaline phosphatase activity in 17-day old fetuses following ~ utero 
TAfl.E 8: FETOHlXIC JWO lERATOlENIC EFFEcrS a= 2,4,5-T IN fvWtMOlS. 
TCOO 
level Gestat iona 1 
Route of Daily dose (~) exposure Maternal Species exposure (mg/kg) cr ess (d~) toxicity Fetotoxicity Teratogenicity Reference 
t-buse (r+R I) oral 35 0.1 6-15 III (P,SM Roll, 1971 
cral 60 O.<E 6-15 FD,1ll (p tEubert and Dill mann, 1972 
SIC 50 1.0 6-14 FD (p B~ et al., 1973 
cral 00 0.1 6-15 + FD ~ Frotberg, 1974 
inhale 216 nY;JIm3 0.1 6-15 + FD ~ Frohberg , 1974 
t-buse (C~l) cral 60 O.<E 6-14 0 0 (p,KM Higtman et a 1., 1977 
cral 1 rrWkg 0.1 12-15 + FD (p CWrtney, 1977 
cral 25O-lD 0.01 7-15 FD short nuzzle Hood et al., 1979 
oral 100 0.5 6-15 + FD,1ll SM Beck, 1981 
Rat (SO) oral 100 0.5 6-10 KM Thompson et al., 1971 
Rat (Wistar) oral 100 0.5 6-15 FD,1ll Khera and tt:Kinley, 1972 
cral 100 1.0 7,8,9 FD 0 Sjoden and Soderberg, 1972 
Hanster cral 100 0.5 6-10 0 FD,1ll absence of e~ 
1 ids, delayed 
ossification, 
Collins and Willians, 1971 
G.I. hermrrh~es 
w 
tIookey cral 10 O.<E 22-:£ 0 0 FD 0 lhJgherty et a 1., 1975 
- = ro effect was observed, + = effect was ooserved, 0 = not evaluated. SIC = subcutaneoos, inhale = inhalation, [G = decreased 
groNth, FO = fetal death, (p = cleft palate, SM = skeletal rnalfonnation, ~ = gross malfonnation, KM = kidney 1TB1fonnation. 
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exposure to 2,4,5-T. Inhalation and subcutaneous administration of 
o 2,4,5-T to pregnant mice also produced teratogenic effects (Sage 
et al., 1973; Frohberg, 1974). 
Subcutaneous injection of 110 mg/kg/day of 2:1 mixture of 2,4-0 
and 2,4,5-T (containing < 1 ppm of TCDD) to pregnant mice on gesta-
tional days 6 to 14 produced embryolethality, growth retardation and 
cleft palate as well as rib anomalies and subcutaneous and renal hemor-
o 
rhages (Sage et al., 1973). No effect was seen at 50 
mg/kg/day of the 2,4-D/2,4,5-T mixture. However, Courtney (1977) 
reported that oral administration of Agent Orange, containing 0.4 ppm 
. 
of TCDD, at 1 mM/kg/day to pregnant mice on gestational days 12 to 15 
produced only growth retardation of the fetuses. 
The teratogenic effects of 2,4,5-T in mice were produced with 
doses as low as 15 and 30 mg/kg/day given on gestational days 6 to 14 
(Gaines et al., 1975). In another experim~nt in mice, 2,4,5-T given 
on days 6 to 15 of pregnancy produced cleft palate at 35 but not at 20 
mg/kg/day (Roll, 1971). The non-teratogenic levels of 2,4,5-T contain-
ing < 0.1 ppm of TCDD, ranged from 20 mg/kg/day (Roll, 1971; Neubert 
and Dillmann, 1972; Seck, 1981), to 40 mg/kg/day (Frohberg, 1974). 
The teratogenic effects of 2,4,5-T in the rat was less definitive 
than in the mouse. Doses ranging from 24 to 50 mg/kg/day of 2,4,5-T, 
containing < 0.5 ppm of TCDD, were not teratogenic in rats (Table 9). 
A dose of 50 mg/kg/day given to rats on gestational days 6 to 15 was 
maternally safe and did not adversely affect fetal survival, growth 
and 'development (Sparschu et al., 1971; Khera and McKinely, 1972). 
Higher doses of 2,4,5-T (100 mg/kg/day), however, produced maternal 
toxicity and fetolithality (Sparschu et al., 1971). Similar fetocidal 
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TABLE 9: NON-TERATOGENIC LEVELS OF 2,4,5-T IN RATS 
Oral dose (mg/kg) 
50 
24 
25 & 50 
Gestational 
exposure (days) 
6-15 
6-15 
6-15 
Reference 
Sparschu et al., 1971 
Emerson et al., 1971 
Khera and McKinley, 1972 
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effects of 2,4,5-T were reported by Khera and McKinley (1972). Thompson 
and coworkers (1971), however, reported kidney malformation in fetal 
rats following prenatal exposure to 100 mg/kg of 2,4,5-T on gesta-
tional days 6 to 10. Also, Sokolik (1973; as cited by Hayes, 1982) 
reported cleft palate and other abnormalities in the newborn rats fol-
lowing prenatal exposure to 50 mg/kg/day of 2,4,5-T. The author, how-
ever, considered that the traces of the dioxin contaminants probably 
contributed to the pathological lesions. The teratogenic effects of 
TCDD, however, were well documented in rats (Courtney and Moore, 1971). 
Konstantinova (1974; 1976; as cited by Hayes, 1982) reported that a 
daily dose of 0.1 mg/kg of 2,4,5-T given during the entire gestational 
period of the rat was the minimal threshold dose for reduced growth, 
increased pathological changes and mortality in the fetus. 
In a three generation reproduction study, the FO rats were fed 
2,4,5-T in the diet at 0, 3, 10, or 30 ppm for 90 days before breeding 
(Smith et al., 1981). Matings were conducted to produce F1, F2, F3a 
and F3b generations while the dietary exposure to 2,4,5-T was contin-
ued. Fertility was decreased for the F3b litters at dietary levels of 
10 ppm. Neonatal survival was significantly decreased in the F2 lit-
ters at 10 ppm, and in the F1, F2 and F3a litters at 30 ppm. Some 
groups of weanlings at 30 ppm showed increased liver weight and 
decreased thymus weight. Reproduction capacity was not significantly 
affected at 3 ppm. 
Low dietary protein increased the adverse effects of 2,4,5-T (250 
or 1000 ppm) on pregnant rats and their progeny (Hall, 1972). The 
placental as well as body, brain, liver and kidney weights of the pro-
geny were decreased. The decreased protein and DNA contents of the 
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placenta, brain, liver and kidneys paralleled the reduction in total 
tissue weights. The decreased maternal gorwth and food intake during 
pregnancy, however, might have contributed to these effects (Hall, 
1972). 
2,4,5-T, containing no detectable levels of TCDD, was fetocidal 
and teratogenic in the hamster when administered orally at 100 mg/kg/ 
day on days 6 to 10 of gestation (Collins and Williams, 1971). At 80 
mg/kg/day the number of pups/litter, fetal weight and surviving neo-
nates decreased without demonstrable teratogenicity (Collins and 
Williams, 1971). 2,4,5-T with or without TCDD (0.1 ppm) produced simi-
lar effects on reproduction outcome in the hamster. However, 2,4,5-T 
containing either 0.5 or 45 ppm of TCDD was teratogenic to the hamster 
at 80 or 20 mg/kg/day (Collins and Williams, 1971). At 2 mg/kg 
2,4,5-T was not teratogenic in the hamster (Gale and Ferm, 1973). 
In the rabbit, 40 mg/kg of 2,4,5-T was not teratogenic or feto-
toxic (Emerson et al., 1971). In sheep, 100 or 113 mg/kg of 2,4,5-T 
were also not teratogenic (Binns and Balls, 1971). 2,4,5-T containing 
0.05 ppm of TCDD was not teratogenic in rhesus monkeys at 0.05, 1 or 
10 mg/kg/day given orally on gestational days 22 to 30. The offspring 
developed and behaved normally (Dougherty et al., 1973; 1975). 
An important aspect of 2,4,5-T exposure in animals was the 
effects on neurobehavioral and neurochemical development of the pro-
geny following ~ utero exposure to non-teratogenic levels. The 
reported behavioral teratogenic effects of 2,4,5-T are presented in 
Table 10. Prenatal exposure of rats to 2,4,5-T resulted in increased 
open field activity of the male offspring (Sjoden and Soderberg, 1972). 
In a later study, Sjoden and Soderberg (1975) reported that 2,4,5-T 
TABLE 10: BEHAVIORAL EFFECTS OF PRENATAL EXPOSURE TO 2,4,5-T 
Treatment Testing 
TCDD level during pregnancy Species age (day) Behavioral effect Reference 
< 1 ppm 100 mg/kg p.o. rat 90 increase exploratory Sjoden and Soderberg, 1972 
on day 7, 8 or 9 activity (males only) 
< 1 ppm 100 mg/kg p.o. rat 35,60 increase open field Sjoden and Soderberg, 1975 
on day 8, 9 or 10 behavior 
rat decrease learning ability Sjoden and Soderberg, 1978 (T-maze & shock avoidance) 
0.03 ppm 7, 13, 27 mg/kg ch icken 14 increase general activity Sanderson and Rogers, 1981 
injected on day increase jumping behavior 
15 of incubation decrease visual learning 
abil ity 
0.03 ppm 25 mg/kg p.o. on rat 65-75 increase ambulation Crampton and Rogers, 1983 
day 8 
100 mg/kg p.o. on rat 65-75 increase ambulation 
day 8 (males only) 
25, 100 mg/kg p.o rat 150 (males) decrease response in 
on day 8 novelty test 
6, 12 mg/kg p.o. rat 65 (males) decrease response in 
on day 8 novelty test 
w 
(J1 
p.o. = orally 
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increased open field activity in both sexes of young rats up to 60 
days old. No effects were seen on postnatal days 95 or 125. Prenatal 
exposure of rats to 2,4,5-T also resulted in learning deficits in a 
water-field maze learning and electric shock-avoidance conditioning 
tests (Sjoden and Soderberg, 1978). More recently Crampton and Rogers 
(1983) reported that a low dose of 2,4,5-T (6 mg/kg on day 8 of gesta-
tion) was behaviorally teratogenic in rats. Behavioral abnormalities 
were also seen in chicks following exposure during the incubation peri-
od to 2,4,5-T (Sanderson and Rogers, 1981). The abnormalities con-
sisted of increased general activity and jumping behavior accompanied 
by decreased visual discrimination learning abilities. The treatment 
of two day old chicks with 2,4,5-T resulted in similar behavioral 
signs with one exception, the discrimination abilities were not 
affected (Sanderson and Rogers, 1981). The mechanisms underlying the 
observed behavioral effects of 2,4,5-T have not been elucidated. 
Sjoden and Soderberg (1978) reported reduced serotonin levels in the 
brains of rats after prenatal exposure to 2,4,5-T. An effect on thy-
roid function (hypothyroidism) was also suggested (Sjoden and 
Soderberg, 1975; 1978). 
The effects of the phenoxy herbicides on male reproductive capa-
bilities have been minimally investigated. Daily oral treatment of 
male mice with 6.25, 12.5 or 25 mg/kg of 2,4,5-T for 10 days resulted 
in a significant reduction in the ability of the prostate gland to 
assimilate radioactive testosterone (Lloyd et al., 1973). In a recent 
study by Lamb et al. (1981), male mice were given diets containing 1:1 
mixture of 2,4-0 and 2,4,5-T with various levels of TCDD (0.16 to 2.4 
~g/kg) for 8 weeks, and mated with untreated females. The maturational 
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development and survival of the offspring in the treated groups were 
not significantly different from those of the controls. Teratogenic 
effects were not observed. However, the effects of paternal exposure 
prior to mating on the postnatal behavior and neurochemical develop-
ment have not been reported. 
Human studies: Limited data are available on the effects of phenoxy 
herbicides on human reproductive performance. Most of the concern 
about the reproductive outcome arose from the occupational exposure of 
humans to these herbicides. The concerns were that herbicide spraying 
increased congenital defects and miscarriage rates among the exposed 
people (Nelson et al., 1979; Hanifyet al., 1981; Smith et al., 1982). 
In a survey conducted in New Zealand by Smith and coworkers (1982), it 
was found that exposure of males and females to 2,4,5-T sprays did not 
have a significant effect on the frequency of congenital defects or 
miscarriages. Similarly, no congenital abnormalities were found in 
Hungary after studying female agricultural workers exposed to 2,4,5-
trichlorophenoxyethanol (Thomas and Czeizel, 1982). Several other 
human epidemiological studies have supported a I/no adverse reproduc-
tive effect property of 2,4,5-TI/ (Nelson et al., 1979; Am. Farm Bur. 
Fed., 1979). In contrast, congenital abnormalities were reported 
among Vietnam children whose parents were exposed to Agent Orange herb-
icide during the war (Norman, 1983). Direct exposure of pregnant 
women to the herbicide reportedly resulted in an increase in the inci-
dence of neural tube defects, deformities of the sensory organs, 
deformities of the limbs, Siamese twins and cleft lip among their off-
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spring. These findings, however, were considered by several reviewers 
to be suggestive rather than conclusive evidence of toxicity (Norman, 
1983). 
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III. MATERIALS AND METHODS 
Animals 
Male (age, 75 to 86 days) and female (age, 66 to 85 days) Sprague 
Dawley rats (Sasco, St. Louis, MO) were used throughout the study. 
All rats were allowed to acclimate to the animal housing environment 
for approximately 10 days before breeding. The housing rooms had a 
constant light-dark cycle (light, 7:30 a.m. to 7:30 p.m.), temperature 
(22 to 23°C), and relative humidity 50~10%. Water and laboratory Rat 
Chow were available ad libitum throughout the study. 
Breeding 
The stage of estrus cycle of female rats was determined by exam-
ining the air-dried vaginal smears (Chahoud and Kwasigroch, 1977). 
Each rat in proestrus or estrus was mated with a male rat overnight. 
The day on which vaginal plugs were first seen was designated day 0 of 
pregnancy. The impregnated animals were weighed and housed individ-
ually in plastic cages containing wood shavings as bedding. 
Treatment of Pregnant Animals 
Table 11 presents the treatment schedule of pregnant rats. The 
pregnant rats were treated by gavage with 2 ml/kg/day of peanut oil 
vehicle (control group I), or 50 (group II), 100 (group III), and 125 
(group IV) mg/kg/day of 1:1 mixture of 2,4-D and 2,4,5-T* (Sigma 
* All chemicals were purchased from Sigma Chemical Co. unless other-
wise mentioned. 
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TABLE 11: TREATMENT SCHEDULE OF PREGNANT RATS 
Gestation Day Procedure 
0 Vaginal plug seen, weigh 
6 - 15 Weigh and gavage: 
Group I: 2ml/kg/day of peanut oil 
vehicle (control) 
Group II: 50 } Group I II: 100 mg/kg/day of 1:1 
Group IV: 125 2,4-D/2,4,5-T 
16 Weigh 
20 Weigh 
Chemical Co., St. Louis, MO) in peanut oil on gestational days 6 
through 15. 
Progeny Allocation for Maturational, Behavioral and Neurochemical 
Tests 
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Rats were allowed to deliver normally. Daily deliveries com-
pleted at 8:30 a.m. were designated as postnatal day (PND) 1. All 
births after 8:30 a.m. were designated as PND O. Offspring in each 
litter were individually weighed and culled to 8 pups of equal number 
of sexes! 1 on PND 1, and weaned on PND 21 (Figure 1 and Table 12). 
Upon weaning, 4 males and 4 females from each litter were housed in 
two separate cages (Table 12). On PND 29 the offspring were rehoused, 
two males or females per cage (Table 12). 
Two males and two females from each litter were tested for matura-
tional and behavioral development (Figure 1 and Table 12). Untested 
animals from each litter were used for brain DNA, RNA, protein, GABA 
and glutamate analyses (Figure 1 and Table 12). A second experiment 
was conducted to obtain pups for determination of brain CA turnover. 
In a third experiment, timed pregnant rats were obtained from Sasco on 
day 4 of gestation, divided into groups (I toIII) and gavaged as des-
cribed in table 11 so as to obtain pups for brain CA, 5-HT and 5-HIAA 
determinations (Table 12). 
Maternal and Birth Records 
Maternal weight gain during pregnancy, and the length of gesta-
tion period were recorded. Litter size, sex ratio and the number of 
dead pups were noted on PND 1. 
FIGURE 1: ALLOCATION OF OFFSPRING FOR TESTINGS 
2M, 2F I (#1,2,5,6) 
8 pups, (4M, 4F) 
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} 2M 2F (83,4,7,8) 
Ancillary measurements 
Surface righting reflex (PND 2-5) 
Negative geotaxis (PND 7-11, 15-17) 
Swimming test (PND 7, 9, 11, 13, 15) 
Olfactory discrimination (PND 9-11) 
GABA, glutamate 
DNA, RNA, protein 
1M, IF 1 (#2, 6) 
Activity wheel (PND 21) 
Activity wheel & amphetamine 
challenge (PND 22,23) ' 
M = male, F = female 
11M, IF (#1, 5) 
Swimming test (PND 21) 
Activity wheel (PND 35) 
t Activity wheel (PND 60) 
Activity wheel & amphetamine 
challenge (PND 61, 62) 
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TABLE 12: MATURATIONAL, BEHAVIORAL AND NEUROCHEMICAL DEVELOPMENTAL 
TEST BATTERY 
Procedure Postnatal day of testing 
Body weight 
Incisor eruption 
Eye opening 
Testes descent 
Vaginal opening 
Weaning, house 4 of each 
Sex/cage 
Rehouse 2 of each sex/cage 
Surface righting reflex 
Negative geotaxis (angle = 25°) 
Negative geotaxis (angle = 45°) 
Olfactory discrimination 
Swimming 
Running wheel activity 
Running wheel activity 
(d-amphetetamine challenge) 
DNA, RNA, Protein, GABA 
Glutamate concentrations 
CA (NE, DA) turnover 
CA (NE, DA) concentrations 
5-HT, 5-HIAA concentrations 
1, 4, 7, 14, 21, 30, 60 
7 to criterion 
12 to criterion 
21 to criterion 
30 to criterion 
21 
29 
2 to 5 
7 to 11 
15 to 17 
9 to 11 
7, 9, 11, 13, 15, 21 
21, 35, 60 
22, 23, 61, 62 
1 (cerebrum, cerebellum) 
15, 22 (cerebellum, neocortex, 
thalamus-hypothalamus) 
3, 9, 15 (whole brain) 
7, 9, 15 (thalamus-hypothalamus, 
pons-medulla, olfactory bulb) 
9, 25 (thalamus-hypothalamus, pons-
medulla) 
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Measurement of Progeny Growth and Maturational Landmarks 
Body weight: The male (Nos. 1 and 2) and female (Nos. 5 and 6) pups 
allocated for behavioral tests and ancillary measurements were indivi-
dually weighed on PND 4, 7, 14, 21, 30 and 60. 
Incisor eruption: Pups (Nos. 1, 2, 5 and 6) were observed daily from 
PND 7 until both upper and lower incisors erupted. 
Eye opening: Pups (Nos. 1, 2, 5 and 6) were observed daily from PND 
12 until eyelids of both eyes were completely separated. 
Testes descent: Male pups (Nos. 1 and 2) were observed daily from PND 
21 until both testes descended. The animal was held underneath the 
forelimbs and its tail was manually extended. This procedure caused 
the descended testes to be pushed down into the genital region where 
they were easily visualized. 
Vaginal opening: Female pups (Nos. 5 and 6) were observed daily from 
PND 30 until the vagina was open. 
Postnatal Neurobehavioral Test Battery 
The behavioral tests used in this study are essentially standard 
methods described for use in mice and rats (Bolles and Woods, 1964; 
Fox, 1965, Altman and Sudarshan, 1975). 
Surface righting reflex: This test measures the integration of neuro-
motor reflex and vestibular function, and was conducted daily between 
8:30 to 10:00 a.m., from PND 2 to 5. Each test pup (Nos. 1, 2, 5 and 
6) was given two trials/day. The pup was placed in dorsal recumbency 
(Figure 2), and timed until it righted itself on all four feet in ~ 2 
seconds on two successive trials. 
Negative geotaxis: This test measures the development of the vesti-
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FIGURE 2: SURFACE RIGHTING REFLEX TEST 
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bular function and the associated integrative motor response to space 
orientation. The behavior was measured daily between 9:00 to 11:00 
a.m. on PND 7 to 11 at an angle of 25 0 (Figure 3a) and on PND 15 to 17 
at an angle of 45 0 (Figure 3b). Each pup (Nos. 1, 2, 5 and 6) was 
placed in a head down position on the center of a demarcated region of 
an inclined surface 5 cm from the base (Figure 3a). Pups were timed 
for completing a 1800 turn. The maximum time allowed was 60 seconds 
on the 25 0 angle slope and 15 seconds on the 450 angle slope. 
Olfactory discrimination test: This test measures nest-seeking 
response mediated by the olfactory system (Gregory and Pfaff, 1971; 
Cornwell-Jones and Sobrian, 1977). The test was conducted daily 
between 2:00 to 4:00 p.m. on PND 9 to 11. The apparatus consisted of 
a plastic container (35X13X12 cm), two small bins which held bedding, 
a wire screen which was placed over the containers and a clear plastic 
cover which was placed over the plastic container (Figure 4). The 
center area under the screen was empty. One end of the container con-
tained a bin filled with soiled bedding from the home cage of the pups 
to be tested. The other end of the container contained the bin filled 
with clean bedding. A 3 cm square area was demarcated in the center 
of the screen for control of animal placement. A line was drawn on 
the screen marking the area above the clean or soiled bedding. The 
pup (Nos. 1, 2, 5 and 6) was placed on the centrally demarcated region 
above the empty area and the latency to enter the side of home cage 
bedding by crossing the designated line with the front paws and head 
was timed. Maximum time allowed was two minutes. Central placement 
of the pup was balanced by alternating the pup facing the experimenter 
or away from the experimenter. Age of home cage bedding was balanced 
(A) 
FIGURE 3A,B: NEGATIVE GEOTAXIS APPARATUS AT 
25° (A) AND 45°(B) ANGLES. 
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FIGURE 4: THE APPARATUS FOR TESTING OLFACTORY 
DISCRIMINATION OF HOME-NEST ODOR. 
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across the groups and averaged 2 to 3 days old at testing. 
Swimming performance: Swimming behavior represents an adaptive 
response to a stressful condition which requires organization and 
coordination of higher centers and neuromuscular responses (Schapiro 
et al., 1970; Salas and Schapiro, 1970). An aquarium (60X60X18 cm) 
filled with water (28 to 29°C) was used for the swimming test between 
10:00 a.m. to 12 noon on PNO 7, 9, 11, 13, 15 and 21. Each designated 
rat (Figure 1) was dropped from about 5 times its own height into the 
center of the aquarium for 5 to 10 seconds. Swimming performance was 
evaluated according to the position of the nose and head (angle) on 
• 
the water surface (Schapiro et al., 1970; Vorhees et al., 1979a). As 
shown in figure 5a,b, performance was scored as follows: O-nose below 
surface, I-nose at or above surface, 2-nose and top of head at or 
above surface but ears still below surface, 3-same as 2 except with 
water line at midear level, 4-same as 3 except water line at bottom of 
ears. After the test the animals were dried and returned to home 
cages. 
Running wheel activity: Running wheel apparatus measures the general 
locomotor acitivty of the animal (Adams and Buelke-Sam, 1981). The 
apparatus (Figure 6) consisted of a wire cage (26X15X13 cm) with a 
running wheel (35 cm in diameter) attached to it (Wahmann MFG Co., 
Baltimore, MO). An entrance with a door at the back side of the cage 
separated the two compartments. The wheels were connected to mechan-
ical counters which recorded the number of revolutions. Food and 
water were available ad libitum during the experiments. At 1:30 p.m. 
on the testing day (beginning on PNO 21), one male (No.2) and one 
female (No.6) from each litter were separately placed in the wire 
(A) 
- 0 1 2 3 
=> 
(B)-Adapted from Schapiro et al., 1970. 
FIGURE 5A,B: ACTUAL PHOTOGRAPHS (A) AND ILLUSTRATIONS 
(B) DESCRIBING THE RATING UNITS TO 
SWIMMING PERFORMANCE. 
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FIGURE 6: RUNNING WHEEL ACTIVITY APPARATUS. 
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cage and allowed to acclimatize to the environment for 30 minutes. At 
the end of the 30 minutes, the door to the running wheel was opened 
allowing the animal to move freely into the wheel chamber. The activ-
ity counts were recorded 18.5 hours later. At the end of the reading 
the animals were returned to the home cages. 
Running wheel activity with amphetamine challenge: The same pups 
(Nos. 2 and 6) tested on PND 21 were injected intraperitoneally with 
0.5 and 1.5 mg/kg of d-amphetamine sulfate (Smith Kline and French 
Lab., Philadelphia, PA) on PND 22 and 23, respectively. The drug was 
given in a volume of 2 ml/kg of saline solution immediately after the 
end of the 3D-minute acclimatization period. Then the door to the 
activity wheel was opened, and the activity was recorded as before. 
On PND 35 and 60, one male (No.1) and one female (No.5) rat 
without previous experience with the running wheel activity (Figure 1) 
were tested for activity as described above. The same animals (Nos. 1 
and 5) were challenged with 0.5 and 1.5 mg/kg of d-amphetamine sulfate 
on PND 61 and 62, respectively, and tested for activity as described 
for progeny numbers 2 and 6 above. 
Neurochemical Analyses 
All rats were killed at different ages (Table 12) in liquid nitro-
gen. Dissection of frozen brains was done at approximately Doe accord-
ing to the method of Glowinski and Iversen (1966). Brain parts were 
wrapped in foil and stored at -70oe until analyzed. In the case of eA 
determination, the assays were completed within 48 to 72 hours of tis-
sue collection. The acidic extracts of 5-HT and 5-HIAA were stored at 
-70oe for about 4 weeks before analyses. 
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DNA, RNA, protein, GABA and glutamate extraction: As outlined in 
figure 7, frozen brain tissues were homogenized in 3 ml of 75% ethanol 
(U.S. Industrial Chemicals Co., New York) containing 1% potassium ace-
tate. The homogenate was centrifuged at 2500 rpm for 10 minutes at 
4°C (Sorval RC2-B, Ivan Sorval, Inc., Norwalk, CT). The supernatant 
was used for GABA and glutamate analyses. The pellet was used to 
extract DNA, RNA, and protein according to a modified Schmidt-
Tannhauser procedure (Munro and Fleck, 1966). The pellet was sus-
pended in 3 ml of 0.2 N of cold perchloric acid or PCA (Fisher Sci. 
Co., Fair Lawn, NJ), kept on ice for 10 minutes and centrifuged at 
10,000 rpm for 10 minutes at 4°C. The supernatant was discarded and 
the pellet resuspended with 1 ml of 0.2 N PCA and the above procedure 
repeated. The pellet was subjected to alkaline digestion with 0.8 ml 
of 0.3 N potassium hydroxide for 60 minutes at 37°C. At the end of 60 
minutes the homogenate was kept on ice for 10 minutes. A 0.5 ml of 
cold 1.2 N PCA was added and the mixture left on ice for another 10 
minutes. The homogenate was centrifuged at 18,000 rpm for 10 minutes 
at 4°C. The supernatant was kept for RNA analysis. This centrifuga-
tion was repeated with 1 ml of 0.2 N PCA and the supernatant was com-
bined with the first RNA extract for RNA estimation. To the pellet, 2 
ml of 5% trichloroacetic acid was added, mixed and heated at 90°C for 
15 minutes. The homogenate was cooled at 4°C for 30 minutes, then 
centrifuged at 10,000 for 20 minutes at 4°C. The supernatant was har-
vested for DNA anaylsis. The final pellet (protein) was solubilized 
in 2 ml of 0.1 N sodium hydroxide at 38 to 40°C for 30 to 40 minutes. 
Some samples resistant to solubilization at 30 to 40°C were heated at 
100°C for an additional 15 minutes in order to complete the solubiliza-
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FIGURE 7: THE PROCEDURE OUTLINE TO EXTRACT GABA, GLUTAMATE, DNA, RNA 
AND PROTEIN. 
Homogenize brain tissue in 75% ethanol containing 
1% potassium acetate 
Centr,ifuge 
~ 
Pellet 
~ 
Homogenize with 0.2 N PCA 
~ 
Centrifuge 
J/ ~ 
Supernatnat Pellet: a. Add 0.2 N PCA 
ice 10 min 
(discard) • 1 b. Mix, stand on 
~ cenlrifuge 
c. Supernatant Pellet: repeat a to c 
(discard) Add 0.3 N KOH 
Mix, incubate 60 min 
at 37°C 
Coolon ice - 10 min 
Add 1.2 N PCA 
Supernatant-freeze 
t 
Evaporate to dryness 
under vacuum 
t 
Add distilled 
water 
J 
Centrifuge 
t 
Supernatant 
of 
GABA, 
dry under 
vaccum 
I t 
Glutamate 
Mix, stand on ice - 10 min 
e. Supernatant 
(RNA) 
" Supernatant 
(DNA) 
t 
d. Centrifuge 
/ ~ 
Pellet: 
Add cold 0.2 PCA 
Mix, repeat d to e 
Add trichloroacetic acid 
Heat at 90°C for 15 min 
Cool to 4°C, 30 min 
Centrifuge 
I \ 
Pellet (Protein) 
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tion of the protein (Lowry et al., 1951; Chiappelli et al., 1979). 
RNA analysis: RNA was determined by the cupric ion catalyzed orcinol 
reaction of Lin and Schjeide (1969). One ml of RNA extract was mixed 
with 1 ml of 1% orcinol reagent (consisting of 2 ml of 50% orcinol in 
95% ethanol and 100 ml of 0.15% cupric chloride in concentrated hydro-
chloric acid (Mallinckrodt, St. Louis, MO). The mixture was heated at 
100°C for 35 minutes and the color was read at 666 nm on a model 2600 
vis-uv Gilford Spectrophotometer (Gilford Instrument Labs., Inc., 
Oberlin, OH). Yeast RNA was used as the standard RNA. 
DNA analysis: A modified diphenylamine colorimetric method of Burton 
(1956) was used to determine brain DNA levels (Geel and Timiras, 1967). 
One ml of DNA extract was mixed with 0.1 ml of 60% PCA and 1 ml of a 
reagent consisting of 1.5 g diphenylamine, 50 ml glacial acetic acid 
(Mallinckrodt), and 0.5 ml of 2% acetaldehyde (Aldrich Chemical Co., 
Inc., Milwaukee, WI) • . The color was allowed to develop overnight at 
30°C and the absorbance read at 600 nm with the spectrophotometer. 
Polymerized calf thymus DNA was used as the standard DNA. 
Protein analysis: The coomassie blue dye-binding method of Bradford 
for protein determination was used (Bradford, 1976; Bio-Rad Labs., 
1979) with minor modifications. Aliquots of 0.1 ml of protein samples 
were diluted with 0.5 ml Tris-KC1 buffer (0.15 M KC1 and 0.01 M Tris 
HC1, pH 7.5) (Chiappelli et al., 1979). A 0.1 ml of this buffered 
protein sample was mixed with 5 ml of the diluted (1 part of concen-
trated dye:4 part distilled water) and filtered coomassie blue G-250 
reagent (Bio-Rad Labs., Richmond, CA). The protein-dye mixture was 
allowed to stand at room temperature for 10 minutes before reading the 
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absorbance at 595 nm using the spectrophotometer. Bovine serum albu-
min was used as the standard protein. 
Glutamate and GABA analyses: The enzymatic-fluorometric methods of 
Graham and Aprison (1966) were used to determine glutamate and GABA 
levels in the brain tissues. An outline of the extraction is shown in 
figure 7. The ethanol extracted brain samples were dried under 
vacuum-freeze dryer (Virtis Co., Inc., New York). The dried sample 
was reconstituted with distilled water, centrifuged at 15,000 rpm for 
30 minutes and the supernatant divided into 50 ~l portions for gluta-
mate and GABA determination. For the GABA analysis, the 50 ~l sample 
was dried under vacuum before conducting the assay. 
To determine glutamate, the following reagents were added to the 
samples: 1 ml of 0.1 M sodium pyrophophate buffer pH 8.4, 20 ~] of 10 
mM of a-nicotinamide adenine dinucleotide, and 10 ~l glutamate-
dehydrogenase (Boehringer Mannheim, Indianapolis, IN). The mixture 
was incubated at 25°C for 30 minutes and the relative fluorescence was 
read with a fluorometer (Fluorometer-4A, Farrand Optical Co., Inc., 
New York) at 470 nm with the excitation wave length at 365 nm. 
To determine GABA, 15 ~l of a reaction mixture (1 ml of 0.1 M 
sodium pryophosphate buffer pH 8.4, 0.2 ml of 1 mM a-nicotinamide 
adenine dinucleotide phophate, 0.2 ml of 0.06 M mercaptoethanol 
(Calbiochem, La Jolla, CA), 0.2 ml of 0.06 M a-ketoglutarate pH 7, and 
0.1 ml GABA-transaminase) was added to each of the dried 50 ~l GABA 
sample tubes and incubated at 38°C for 30 minutes. Fifty ~l of alka-
line phosphate buffer (0.4 M Na3P04.12H20/0.2 M Na2HP04.7H20) was 
added to the GABA mixture and incubated at 60°C for 15 minutes. A 50 
~ aliquot of the GABA mixture was transferred into tubes containing 
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0.1 ml of 0.03% alkaline hydrogen peroxide, mixed and heated at 60°C 
for 10 minutes. One ml of distilled water was added and the relative 
fluorescence was read at 470 nm with the excitation wave length at 365 
nm. 
Catecholamine analysis: The electrochemical detection method of 
Mefford (1981) was used with some modifications to determine NE and DA 
levels in brain tissues. As outlined in figure 8, brain tissues were 
homogenized in 0.1 N PCA (approximately 30 mg tissue/0.5 ml PCA) con-
taining 1 mM disodium EDTA and dihydroxybezylamine (DHBA) as the inter-
nal standard, and centrifuged at 15,000 rpm for 20 minutes at 4°C. To 
0.4 ml of the supernatant were added 20 mg of acid-washed heat acti-
vated alumina (Bioanalytical Systems, West Lafayette, IN) and 1.1 ml 
of 0.5 M Tris buffer (pH 8.6). The tubes were shaken for 5 minutes 
and centrifuged. The supernatant solution was aspirated and the alu-
mina washed twice with 1 ml of distilled water. The CA and DHBA were 
eluted with 0.25 ml of 0.1 N PCA, centrifuged and 20 ~l aliquot of the 
eluate was analyzed by high performance liquid Chromatography (HPLC) 
using electrochemical detection (Series 10 LC, LC-4B amperometric 
detector, Perkin-Elmer Corp., Norwalk, CT). Samples were chromato-
graphed on a reverse-phased C18 (10 ~m) column (Perkin-Elmer), using a 
solvent of 10% aqueous methanol (Fisher Sci. Co.), 0.1 Msodium ace-
tate, 0.03 M citiric acid and 0.0003 M octyl sodium sulfate (Eastman 
Kodak Co., Rochester, NY) at a pH of 4.8. A flow rate of 1 ml/minute 
'was maintained. A TL-5 flow cell with glassy carbon and an Ag/Cl ref-
erence electrode was used (Bioanalytical Systems). The detector was 
at 0.62 V against Ag/Cl reference electrode. ~igure 9 represents the 
chromatogram of representatives of the standards and samples. The 
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FIGURE 8: THE PROCEDURE OUTLINE TO EXTRACT CA, 5-HT AND 5-HIAA. 
Homogenize brain tissue in 0.1 N PCA 
~ 
Centrifuge 
* Supernatant (5-HT, 5-HIAA, NE, DA) I 
Pass through activated 
Sep-Pak C18 cartridges 
to adsorb 5-HT, 5-HlAA 
+ 
Wash with distilled water 
+ 
5-HT, 5-HIAA eluted with 
60% methanol 
Inject 20-30 ~l of eluate 
into HPLC 
Add activated alumina and Tris buffer 
pH 8.6, to adsorb NE, DA 
! 
Shake 5 min. 
~ 
Centrifuge 
! 
Wash twice with distilled water 
~ 
NE, DA eluted with 0.1 N PCA 
~ 
Inject 20 ~l of eluate into HPLC 
FIGURE 9: CHROMATOGRAMS OF NE, DA AND DHBA IN THE STANDARD 
SOLUTION AND BRAIN SAMPLES. POTENTIAL 0.62 V, RANGE 
5 NA, FLOW RATE 1 ML/MIN, CHART SPEED 30 CM/HR. 
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detector range was set at 5 nA. 0.4 m1 of NE (34 ng/m1) and 0.4 m1 of 
DA (38 ng/m1) standards were processed in duplicate along with the 
samples to obtain an eluted volume of 0.25 ml. The recovery of the 
standards were 65 to 70%. The peak height ratio of NE/DHBA and 
DA/DHBA were used to measure the NE and DA concentration of the 
unknown samples as follows: 
Cone. of unknown NE = (NE/DHBA) unknown X (cone. NE) known 
(NE/DHBA) known 
Cone. of unknown DA = (DA/DHBA) unknown X (cone. DA) known 
(DA/DHBA) known 
Estimation of CA turnover parameters: Whole brain NE and DA turnover 
rate, rate constant of efflux, and turnover time were determined on 
PND 3, 9 and 15 by the enzyme inhibition method (Brodie et a1., 1966; 
Slotkin et a1., 1982). a-Methy1-tyrosine was used to inhibit the rate 
limiting enzyme tyrosine hydorxylase (Spector et a1., 1965, Brodie et 
a1., 1966). In each treatment group, male and female pups from 2 to 3 
litters were injected intraperitoneally at 8:30 a.m. either with 300 
mg/kg of a-methyl-para-tyrosine methyl ester (a-MPT) as the free base 
or saline vehicle at 2 m1/kg body weight. The saline treated rats 
were killed after injection (0 hr) in liquid nitrogen. Rats injected 
with a-MPT were killed four hours after administration. After deter-
mination of CA concentration at 0 hr and 4 hr after the blockade of 
tyrosine hydroxylase bya-MPT, the turnover parameters were calculated 
from the exponential rate of decline of CA concentration versus time 
according to Brodie et al. (1966): 
Rate of CA synthesis = k[CAJO where k is the rate constant of CA 
efflux. [CAJO is the initial concentration at 0 hr. A plot of log 
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[CA] concentration versus time yields a straight line, the slope of 
which is 0.434 times k. Turnover time is 11k. 
5-HT and 5-HIAA Analyses: C18 extraction columns (Sep-Pak C18 car-
tridges, Waters Associates, Milford, MA) were used during the extrac-
tionof 5-HT and 5-HIAA. Indole compounds adsorb to C18 particles 
I 
under proper conditions, and then are selectively eluted with organic 
solvents (Craig and Savage, 1980; Falkowski and Wei, 1981). 
Different portions of the same brain extracts were used for 
either CA or 5-HT and 5-HIAA analyses (Figure 8). After homogeni- ' 
! 
zation of brain tissues (in 0.1 N PCA containing 1 mM disodium EDTA) 
and centrifugation (at 15,000 rpm for 20 minutes at 4°C), 0.2 to 0.5 
ml of the supernatant solution were passed under vacuum through the 
Sep-Pak C18 cartridges preconditioned with 2 ml of methanol and 5 ml 
distilled water, and washed with 2 ml of distilled water. 5-HT and 
5-HIAA were then eluted off the extraction cartridges with 1 ml of 60% 
methanol. A 20 to 30 ~l of the eluent was analyzed by HPLC using elec-
trochemical detection. Samples were chromatographed on reverse-phase 
C18 column using a solvent of 12% methanol, 0.1 M sodium acetatel 
citrate buffer containine 50 mg/L of disodium EDTA. A flow rate of 
1.2 ml/minute was maintained. A TL-5 flow cell with glassy carbon and 
Ag/C1 reference electrode were used. The detector potential was at 
0.6 V, and the range at 2 nA. The 5-HT and 5-HIAA standard solutions 
(50 ng/ml) were subjected to identical sample extraction procedure. 
The external standard method was used to calculate the concentrations 
of 5-HT and 5-HIAA in the tissue samples. Figure 10 represents chro-
matograms of representatives of the standards and samples. The recov-
FIGURE 10: CHROMATOGRAMS OF 5-HT AND 5-HIAA IN THE STANDARD 
SOLUTION AND BRAIN SAMPLES. POTENTIAL 0.6 V, 
RANGE 2 NA, FLOW RATE 1.2 ML/MIN, CHART SPEED 30 
CM/HR. 
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ery of the standards was 80 to 90%. Correction was made for the recov-
ery. 
Statistical Analyses 
Maternal and offspring weight gains, and behavioral tests were 
analyzed by the repeated measure analysis of variance (ANOVA), fol-
lowed by the least significant difference (LSD) test. Treatment 
effect on swimming performance and surface righting reflex was further 
analyzed by the non-parametric Mann-Whitney U-test. Other maternal 
and offspring parameters were analyzed by ANOVA followed by LSD, 
. 
except mortality which was analyzed by the Chi square test. Treatment 
effects on neurochemical parameters were analyzed by unpaired student 
t-test. On all the tests (except neurochemistry) the individual data 
in each litter was averaged, where appropriate, and the litter was 
used as the experimental unit with prenatal treatment considered as 
between group variable. The accepted level of significance was 
P<0.05. 
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IV. RESULTS 
Maternal Weight Gain 
Relative to the control group, administration of 50 mg/kg of 1:1 
mixture of 2,4-0/2,4,5-T did not significantly affect maternal weight 
gain during the gestation period (Figure 11). Pregnant rats treated 
with 100 or 125 mg/kg of 2,4-0/2,4,5-T gained significantly less 
weight than the control on gestational days 11 to 20 (Figure 11). No 
other signs of phenoxy herbicide induced toxicity were seen in the 
pregnant rats. 
Gestational and Birth Records 
Gestational and birth records of the control and 2,4-0/2,4,5-T 
treated groups are shown in Table 13. The gestational lengths were 
not significantly affected by the treatments (Table 13). 
No gross anomalies were observed in any group of pups based upon 
external examination on PNO 1. No significant reduction was found on 
PNO 1 in the number of live pups in the 50 mg/kg group when compared 
with the control (Table 13). Increasing the dose of 2,4-0/2,4,5-T to 
100 and 125 mg/kg resulted in a significant reduction (15 and 23% of 
control value, respectively) in the number of live pups on PNO 1 
(Table 13). 
The high dose of 2,4-0/2,4,5-T mixture (125 mg/kg) significantly 
increased the number of dead pups (mortality) on PNO 1 (Table 13). 
PNO 1 mortality in the 50 and 100 mg/kg groups was not significantly 
different from control (Table 13). The ratios of males to females 
were not affected by treatments (Table 13). 
FIGURE 11: WEIGHT GAIN. OF PREGNANT RATS TREATED BY GAVAGE WITH 
VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 
6 TO 15. N = 16 TO 36 RATS/GROUP. 
VALUES OF 100 AND 125 MG/KG DOSE GROUPS ARE 
SIGNIFICANTLY DIFFERENT FROM CONTROLS FROM DAY 11 TO 
20 BY ANOVA [F(3,107) = 116, P<O.OOOl] AND LSD, 
P<0.05. 
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TABLE 13: GESTATIONAL AND BIRTH RECORD OF PREGNANT RATS TREATED ORALLY WITH VEHICLE OR 
2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
No. of Live Total No. PND 1 Weight 
No. of Gestational pups/litter M:F ratio/ dead pups (g) 
Group 1 i tters length (days) on PND 1 1 itter on PND 1 M F 
Vehicle 
Control 36 21.8+0.1 13+0.3 1.5+0.4 · 5 7.2+0.1 6.9+0.1 
50 mg/kg 29 21. 9+0.1 12+1.0 1.4+0.2 5 7.1+0.1 6.8+0.1 
100 mg/kg 30 22.1+0.1 11+1.0a 1.2+0.3 5 7.1+0.1 6.8+0.1 
125 mg/kg 16 22.1+0.1 10+1.0a 1.0+0.1 gb 6.8+0.2 6.7+0.1 
Values are means + SEM. 
M = male, F = female, PND = postnatal day 
a Significantly different from the control value by ANOVA [F(3,107) = 3.3, P<0.05] and LSD, 
P<0.05. 
b Significantly different from the control value by [X2(1) = 9.7, P<0.005]. 
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On PND 1 no significant treatment effects were found on measure-
ments of body weights of male or female offspring (Table 13). The 
body weights of males and females within a group were not signifi-
cantly different from each other (Table 13). 
Progeny Growth and Maturation 
Relative to the control group, prenatal exposure to 50 and 100 
mg/kg of 2,4-D/2,4,5-T did not significantly affect postnatal body 
weight gains of the male and female offspring up to PND 60 (Figure 12). 
In the 125 mg/kg group, however, body weights of the male and female 
offspring were significantly lower than those of the control offspring 
only on PND 60 (Figure 12). The difference from the control value, 
however, was only 3% for either sex. As the progeny matured, male 
offspring within the control and treated groups significantly gained 
more weight than their female littermates on PND 30 and 60 (Figure 
12). 
The times of appearance of physical landmarks of maturation in 
the offspring of control and treated groups are shown in Table 14. 
There were no significant differences in the times of incisor erup-
tion, eye opening, vaginal opening, or testicular descent. Within a 
group, there were no sex-related differences in the times of incisor 
eruption or eye opening (Table 14). 
Postnatal Behavior 
Surface righting reflex: The control group of offspring showed a pro-
gressive improvement in its response (i.e. a decreased response 
time) to surface righting reflex, whereas in the treated groups there 
FIGURE 12: POSTNATAL BODY WEIGHTS OF MALE AND FEMALE RATS 
PRENATALLY EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T 
. 
MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
N = 12 TO 26 LITTERS/SEX/GROUP. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS, BY ANOVA 
[F(3,148) = 3.8, P<0.02] AND LSD, P<0.05. 
BODY WEIGHTS OF MALES ARE SIGNIFICANTLY DIFFERENT 
FROM FEMALE LITTERMATES ON DAY 30 AND 60 BY ANOVA 
[F(1,148) = 1051, P<O.OOOl] AND LSD, P<0.05. 
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TABLE 14: THE AGE (DAY) OF APPEARANCE OF PHYSICAL LANDMARKS IN DEVELOPING RATS PRENATALLY 
EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
Incisors Eruption Eyes Opening Testes Descent Vaginal Opening 
Group Male Female Male Female 
Vehicle 
Control 10.7+0.1 10.4+0.1 15.1+0.2 14.9+0.1 ·23.7+0.2 32.2+0.3 
50 mg/kg 10.7+0.2 10.6+0.2 15.2+0.1 14.8+0.1 23.7+0.2 32.1+0.4 
100 mg/kg 10.7+0.1 10.4+0.1 14.8+0.1 14.7+0.2 23.2+0.2 32.1+0.5 
125 mg/kg 10.9+0.2 10 .8+0.1 15.2+0.2 15.0+0.1 23.9+0.2 31. 7+0.4 
Values are means + SEM for 13 to 23 litters/group. 
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were significant ontogenic delays in surface righting reflex ability 
during the test period (Figure 13). There was a significant treat-
ment-induced reduction in the percentage of pups righting within 2 
seconds on PND 2 and 3 at 125 and 100 mg/kg, respectively (Figure 13). 
On PND 4 and 5, surface righting reflex was significantly delayed in 
all the treated groups (Figure 13). 
Negative geotaxis: The ontogeny of negative geotaxis response at 25 0 
angle was significantly delayed in male and female offspring in the 
100 and 125 mg/kg groups (Figure 14). Mean latencies to turn 1800 in 
male offspring prenatally exposed to 100 and 125 mg/kg of 2,4-D/ 
2,4,5-T were significantly increased on PND 9 to 11 (Figure 14). In 
females, latencies were significantly increased on PND 9 and 10. 
Although longer times were needed for the male offspring in the 
50 mg/kg group to complete the 1800 turn, there was no significant 
treatment effect (Figure 14). In contrast, the female offspring of 
the 50 mg/kg group manifested a significant increase in turning laten-
cy from the female controls on PND 9 (Figure 14). No sex-related dif-
ference within a group was observed in response to negative geotaxis 
test at 250 angle (Figure 14). 
Repeating the negative geotaxis test at 450 angle on PND 15 to 
17, produced a significant treatment effect on both sexes on mean la-
tency to turn 1800 (Figure 15). Mean latencies were significantly 
increased from control values in males of the 50 and 125 mg/kg groups 
on PND 15, and in all the treated groups on PND 17 (Figure 15). The 
mean latencies of females were significantly increased from control 
values in the 125 mg/kg group on PND 15, in the 50 and 100 mg/kg 
FIGURE 13: SURFACE RIGHTING REFLEX RESPONSE OF RATS PRENATALLY 
EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON 
GESTATIONAL DAYS 6 TO 15. 
VALUES ARE MEANS ~ SEM FOR 13 TO 23 LITTERS/GROUP. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS BY ANOVA 
[F(3,65) = 8.8, P<O.0001] AND MANN-WHITNEY U-TEST, 
P<O.05. 
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FIGURE 14: DEVELOPMENT OF NEGATIVE GEOTAXIS REFLEX (ANGLE = 
25°) IN MALE AND FEMALE RATS PRENATALLY EXPOSED TO 
VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 
6 TO 15. 
N = 13 TO 23 LITTERS/SEX/GROUP. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS BY ANOVA 
[F(3,129} = 6.9, P<O.0002] AND LSD, P<O.05. 
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FIGURE 15: DEVELOPMENT OF NEGATIVE GEOTAXIS REFLEX (ANGLE = 
45°) IN MALE AND FEMALE RATS PRENATALLY EXPOSED TO 
VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 
6 TO 15. 
N = 13 TO 23 LITTERS/SEX/GROUP. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS BY ANOVA 
[F(3,126} = 6.9, P<0.0002] AND LSD, P<0.05. 
79 
10 
8 
V'l 
0 
z: 
0 
u 
U.J 
V'l 
z: 
6 
c:: 
::::> 
I-
0 
I-
>-
u 4 
z: 
U.J 
l-
<C 
-' 
z: 
<C 
U.J 
~ 2 
o 
• NEGATIVE GEOTAXIS (ANGLE=45) 
(MALES) (FEMALES) 
* 
* ~ * 
.6, ....... " ~
.... :-....~. ** 
. ~.~ ........... -Q). 
~ . 
................. ~.-. * 
~/ .~~.:-::.-* ..". ..... 
cy * 
• vehicle control 
o 50 mg/kg 
A 100 mg/kg 
... 125 mg/kg 
15 16 1 7 1 5 1-6------ 1 7 
DAY OF AGE 
ex> 
o 
81 
groups on PND 16, and in all the treated groups on PND 17. The laten-
cies to complete the 1800 turn in males and females within a group 
were not significantly different from each other (Figure 15). 
Olfactory discrimination: The ontogeny of olfactory discrimination 
response was significantly delayed in male and female offspring prena-
tally exposed to 100 and 125 mg/kg of 2,4-D/2,4,5-T mixture (Figure 
16). Relative to control values, mean latencies to reach the side of 
home cage bedding were significantly increased in male and female prog-
eny in the 100 and 125 mg/kg groups on PND 9 (Figure 16). This effect 
was extended to PND 10 and 11 in the males of the 125 mg/kg group. In 
females of the 125 mg/kg group, the delay was also observed on PND 11 
but not PND 10. The responses of male and female offspring in the 50 
mg/kg group to olfactory discrimination test were not significantly 
different from control values (Figure 16). No sex-related difference 
within a group was observed in the response to the olfactory discrimin-
ation test. 
Swimming: Examination of swimming performance (PND 7 to 21) indicated 
that the mean swimming angle scores of all the 2,4-D/2,4,5-T exposed 
groups were significantly lower than control values on PND 7 (Figure 
17). The scores of the treated groups were not significantly differ-
ent from control values on PND 9 to 21, except for a significant reduc-
tion on PND 9 in the 125 mg/kg group (Figure 17). Swimming scores of 
the males and females within a group were not significantly different 
from each other. 
FIGURE 16: DEVELOPMENT OF OLFACTORY DISCRIMINATION OF MALE AND 
FEMALE RATS PRENATALLY EXPOSED TO VEHICLE OR 
2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
VALUES ARE MEANS ~ SEM FOR 13 TO 23 LITTERS/SEX/ 
GROUP. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS BY ANOVA 
[F(3,128) = 22.6, P<O.0001] AND LSD, P<O.05. 
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FIGURE 17: SWIMMING PERFORMANCE OF DEVELOPING MALE AND FEMALE 
RATS PRENATALLY EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T 
MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
N = 13 TO 23 LITTERS/SEX/GROUP. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS BY ANOVA 
[F(3,129) = 24.8, P(0.0001] AND MANN-WHITNEY U-TEST, 
P(0.05. 
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Running wheel activity: The age and sex related effects of 2,4-0/ 
2,4,5-T administration on offspring running wheel activity during 18.5 
hr period (2:00 p.m. to 8:30 a.m.) are presented in figure 18a,b and 
table 15. On PNO 21, the mean activity counts of males and females in 
the treated groups were not significantly different from control val-
ues (Figure 18a,b). However, the activity of the males in the 125 
mg/kg group tended to be higher than those of the control males on PNO 
21. 
Following d-amphetamine sulfate challenges on PNO 22 and 23, the 
running wheel activity counts of the males in the 125 mg/kg group were 
• 
significantly higher than those of the control males (Figure 18a). In 
contrast the mean activity counts of the females in the treated groups 
were not significantly different from the control values following 
amphetamine challenges on PNO 22 and 23 (Figure 18b). 
No significant treatment effects were observed on running wheel 
activities of the treated groups on PNO 35 and 60 (Table 15). Ampheta-
mine challenges on PNO 61 and 62 failed to reveal any subtle treatment 
effects in the 2,4-0/2,4,5-T exposed offspring (Table 15). Within 
each group, activity counts of females were significantly higher than 
those of their male littermates on PNO 60, 61 and 62 (Table 15). 
Neurochemistry 
Glutamate and GAB A contents: In one-day old pups in the 50 and 125 
mg/kg groups the glutamate levels in the cerebrum were significantly 
reduced (9 and 13%, respectively) below control values (Table 16). 
Glutamate reductions in the cerebellum were 23 and 11%, respectively 
FIGURE 18A,B: RUNNING WHEEL ACTIVITY OF MALE (A) AND FEMALE (B) 
RATS PRENATALLY EXPOSED TO VEHICLE OR 2,4-0/ 
2,4,S-T MIXTURE ON GESTATIONAL DAYS 6 TO IS. 
VALUES ARE MEANS! SEM FOR 10 TO 18 RATS/GROUP. 
BEFORE TESTING, ON PND 22 AND 23, THE RATS WERE 
INJECTED I.P. WITH O.S AND 1.S MG/KG OF D-AMPHET-
AMINE SULFATE RESPECTIVELY. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS BY ANOVA 
[F(3,100) = 8.4, P<O.OOOl] AND LSD, P<O.OS. 
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TABLE 15: RUNNING WHEEL ACTIVITY (NUMBER OF ROTATIONS/18.5 HR) OF RATS PRENATALLY EXPOSED TO VEHICLE OR 
2~4-D/2~4~5-T MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
Group PND 35 PND 60 PND 61 a PND 62 b 
M F M F M F M F 
Vehicle 
Control 576+76 711+113 510+73 1219+160* 633+250 1017+137* 368+52 1595+267* 
50 mg/kg 574+ 116 774+63 511+83 1376+242* 411+73 1284+183* 390+60 1738+121* 
100 mg/kg 563+ 133 736+122 372+42 1473+365* 372+43 901+110* 460+66 1306+143* 
125 mg/kg 682+194 891+291 428+54 1l30+l31* 371+61 1058+140* 499+107 1197+356* 
Values are means + SEM for 8 to 15 rats/sex/group. 
d - Amphetamine sulfate challenges (a = 0.5 mg/kg and b = 1.5 mg/kg~ i.p.). 
PND = postnatal day~ M = male~ F = female. 
* Significantly different from male littermates within a group by ANOVA [F(1~77) = 188~ P<O.OOOl] and LSD~ 
P<0.05. 
~ 
o 
TABLE 16: THE REGIONAL DISTRIBUTION OF GLUTAMATE AND GABA IN THE BRAINS OF RATS AT VARIOUS AGES 
FOLLOWING PRENATAL EXPOSURE TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE 
ON GESTATIONAL DAYS 6 TO 15. 
Age 
Brain Region (day) o mg/kg 50 mg/kg 125 mg/kg o mg/kg 50 mg/kg 125 mg/kg 
Glutamate (jJ mol/g wet tissue) GABA (jJ mol/g wet tissue) 
Cerebrum 1 4.17+0.12 3.81+0.13a 3.61+0.15b 0.69+0.02 0.70+0.02 
Cerebellum 1 2.88+0.11 2.21 +0.15 c 2.56+0.09d 1.03+0.04 . 0.92+0.06 
Cerebellum 15 3.96+0.21 4.09+0.21 4.36+0.27 0.73+0.06 0.69+0.04 
Thalamus-
Hypotha 1 amus 15 5.21+0.35 5.49+0.35 5.31+0.54 2.32+0.17 2.49+0.18 
Neocortex 15 8.85+0.84 8.28+0.85 7.86+0.62 1.68+0.14 1. 53+0.17 
Thalamus-
Hypothal amus 22 5.83+0.52 4.89+0.96 5.56+0.40 1. 94+0.09 1.89+0.30 
Neocortex 22 8.35+0.81 7.09+0.85 6.94+0.60 1.51+0.12 1. 37+0.06 
Values are means + SEM. 
Number of rats (N)/group = 8 to 12, except at age 22 day, N = 5. 
Significantly different from the appropriate control values by student t- tests: 
at(19) = 2.0, P<0.05. 
bt(19) = 3.0, P<0.005. 
Ct(20) = 3.7, P<0.005. 
dt(20) = 2.1, P<0.025. 
0.74+0.03 
0.98+0.04 
0.70+0.04 
2.31+0.24 
1.42+0.15 
2.34+0.22 
1. 39+0.11 
92 
(Table 16). No significant changes occurred in glutamate levels in 
any of the regional brain areas examined on PNO 15 and 22 (Table 16). 
The levels of GABA in the cerebrum, cerebellum, neocortex or thalamus-
hypothalamus (PNO 1, 15 or 22) were not significantly affected by the 
2,4-0/2,4,5-T treatments (Table 16). 
Protein, DNA and RNA contents: With the exception of a significant 8% 
reduction in RNA contents of neocortex on PNO 22 in the 125 mg/kg 
group rats, there were no significant treatment effects on regional 
brain contents of protein and nucleic acids on PNO 1, 15 or 22 (Table 
17). 
In general, the developmental effects of 2,4-0/2,4,5-T treatments 
on the regional brain protein:ONA and RNA:ONA ratios were not signifi-
cant (Table 18). However, on PNO 22 the protein:ONA ratios in the 
thalamus-hypothalamus of the 50 and 125 mg/kg groups were signifi-
cantly reduced below control values by 9 and 17%, respectively (Table 
18). 
Catecholamine turnover: The steady-state (0 hr) whole brain NE and OA 
levels in the treated groups were not significantly different from 
control values on PNO 3 and 9 (Table 19). On PND 15, however, whole 
brain NE levels significantly increased above control values in the 50 
and 100 mg/kg groups by 10 and 18%, respectively; whereas DA levels 
significantly increased by 24% in the 100 mg/kg treatment group (Table 
19). 
When compared to control values, whole brain DA turnover rates 
and efflux rate constants in the 50 and 100 mg/kg groups of rats were 
T.A&.E 17: THE REGI(NAL DISlRIBJTIOO (F PROTEIN, 0Nl\ AND RNl\ IN TI£ BRAINS (F RATS (F VAAIOJS PUES FQLOWIf'{l PRENl\TAl 
EXPCRRE TO VEHIClE (R 2,4-0/2,4,5-T MIXME 00 CI:STATI(NAL DAYS 6 TO 15. 
~ 
Brain regioo (day) o rTg/kg 50 ng/kg 125 rTg/kg o ng/kg 50 rTg/kg 125 ng/kg o rrg/kg 50 rrg/kg 125 rrg/kg 
Protein (rrg/g \\et tissue) rnn. (l1Y;l/g \\et tissue) RNl\ (rrg/g \\et tissue) 
Cerebrun 1 49.85+2.40 51.33+2.:E 46.28+2.00 3.14+0.23 3.26+0.21 3.19+0.18 4.16+0.32 4.07+0.31 3.71+0.27 
Cerebe llllTl 1 48.00+-1.71 48.11+1.61 44.~+2.10 1.ffi+<J.Oi 1.96+0.12 1. 80+{). 32 3.10+0.20 3.17+0.22 3.14+0.22 
-
Cerebe llllTl 15 75.35+1.69 77.@-1.59 77.78+1.11 5.97+0.19 5.94+0.25 6.37+0.14 3.47+0.15 3.67+0.16 3.83+0.11 
ThalcmJs-
H}1)otha 1 cmJS 15 54.43+2.00 SS.ot+1.07 54.79+2.22 1.03+O.Oi O.95+O.~ 0.97+O.~ 2.81+0.05 2.8}t{).11 2.91+0.05 
Neocortex 15 56.18+1.68 56.73+1.~ 57.11+1.55 0.99+0.03 l.oo+O.CE 1.10+0.CE 2.85+O.CE 2.00+0. Oi 3.10+0.12 
ThalcmJs-
H}1)otha 1 cmJS 22 59.25+7.~ 61.75+2.22 61.25+1.~ O. 93+0. ot O.96+0.ot 1.ot+O.~ 2.50+0.07 2.8}t{).10 2.68+0.11 
Neocortex 22 72. 57+1.:E 74.64+4.00 77 .ot+1.45 1. 00+0. ot 0.97+0.05 1.10+0.~ 2.00+0.05 2.79+0.~ 2.66+0.07* 
Val ues are rre<r1S + ~M. 
Nurrber of rats (N)/group = 9 to 12, except in neocortex (dqy 22), N = 5. 
* Significantly different fran the appropriate control values by stu<Ent t-test: t(8) = 2.4, P<0.~5. 
TABLE 18: THE REGIONAL DISTRIBUTION OF PROTEIN:DNA AND RNA:DNA RATIOS IN THE BRAINS OF RATS AT 
VARIOUS AGES FOLLOWING PRENATAL EXPOSURE TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE 
ON GESTATIONAL DAYS 6 TO 15. 
Age 
Brain Region (day) o mg/kg 50 mg/kg 125 mg/kg o mg/kg 50 mg/kg 125 mg/kg 
Protein/DNA RNA/DNA 
Cerebrum 1 16.47+0.97 15.92+0.58 14.63+0.79 1. 36+0.09 1.25+0.05 1.17+0.06 
Cerebellum 1 26.46+1.00 25.49+1.93 25.55+1. 76 1.69+0.12 1.66+0.14 1. 76+0.11 
Cerebellum 15 12.75+0.56 13.22+0.77 12.26+0.36 0.59+0.03 0.64+0.04 0.61+0.03 
Thalamus-
Hypothalamus 15 54.94+3.26 57.77+0.65 56.50+2.84 2.82+0.17 2.91+0.11 3.0+0.09 
Neocortex 15 56.83+1.40 53.49+2.74 52.73+2.46 2.89+0.09 2.71+0.09 2.89+0.19 
Thalamus-
Hypothalamus 22 70.98+2.21 64.68+2.59a 59.03+1.68b 2.72+0.10 2.98+0.21 2.60+0.13 
Neocortex 22 67.42+2.45 75.15+2.42 70.32+2.71 2.67+0.07 2.93+0.22 2.50+0.10 
Values are means + SEM. 
Number of rats (N)/group = 9 to 12, except in neocortex (day 22), N = 5. 
Significantly different from the appropriate control values by student t-tests: 
at(16) = 1.9, P<0.05). 
bt(17) = 4.4, P<0.0005. \0 
~ 
TABLE 19: STEADY-STATE (0 HR) WHOLE BRAIN CATECHOLAMINE CONTENT (NG/G WET TISSUE) IN DEVELOPING RATS 
PRENATALLY EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
Group 
Vehicle 
Control 
50 mg/kg 
100 mg/kg 
NE 
127.7+2.3 
123.0+4.9 
121.6+4.2 
PND 3 
DA 
181. 0+6.2 
164.9+8.7 
175.2+6.2 
PND 9 
NE 
128.4+4.5 
125.9+5.8 
114.0+7.7 
DA 
218.9+7.9 
234.7+8.4 
223.4+11.1 
Values are means + SEM of 7 to 10 rats in each group at each age. 
PND = postnatal day. 
NE = norepinephrine, DA = dopamine. 
PND 15 
NE 
214.3+4.9 
234.7+5.3a 
252.7+10.5b 
Significantly different from the appropriate control values by student t-tests: 
at(13) = 2.8, P<O.Ol 
bt(12) = 3.3, P<0.005 
Ct(12) = 6.6, P<O.OOl 
DA 
441.9+10.3 
449.3+6.0 
549.3+12.3c 
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significantly reduced on PND 3 (Table 20). The percentage of reduc-
tion in the 50 and 100 mg/kg groups were 39 and 28%, respectively, for 
the turnover rates and 36 and 31%, respectively, for the efflux rate 
constants. In contrast, the DA turnover times were significantly 
increased by 53 and 71% in the 50 and 100 mg/kg groups, respectively 
(Table 20). No significant alterations in DA turnover parameters 
occurred on PND 9 and 15. Norepinephrine turnover rates of the 
treated groups were not signifiantly different from control values on 
PND 3, 9 and 15 (Table 20). No significant changes were seen in the 
NE rate constant of efflux and its turnover time in pups prenatally 
exposed to the low dose on PND 3, 9 and 15 (Table 20). In the 100 
mg/kg group, however, the rate constant of the NE efflux significantly 
decreased by 19% and turnover time increased by 25% on PND 15 (Table 
20). 
Catecholamine contents: The levels of NE and DA in different brain 
areas of the developing pups are presented in tables 21 and 22, and 
figure 19. On PND 7, DA levels in the thalamus-hypothalamus of pups 
prenatally exposed to 50 and 100 mg/kg of 2,4-D/2,4,5-T were signifi-
cantly reduced below control values by 34 and 38%, respectively (Table 
21). No significant treatment effects were seen in DA levels in the 
thalamus-hypothalamus on PND 9 and 15. In the pons-medulla of the 50 
and 100 mg/kg treatment groups, DA levels were significantly reduced 
by 46 and 48%, respectively, below control values on PND 7 (Table 22). 
In the 50 mg/kg treatment group, DA levels in the pons-medulla were 
significantly below control values by 51% on PND 15 (Table 22). The 
DA levels in the pons-medulla of the 100 mg/kg group were signifi-
TABLE 20: WHOLE BRAIN CATECHOLAMINES (CA) TURNOVER RATE, RATE CONSTANT OF EFFLUX AND TURNOVER TIME IN 
DEVELOPING RATS PRENATALLY EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE 
GESTATIONAL DAYS 6 TO 15. 
PND 3 PND 9 PND 15 
Group NE UA NE UA NE UA 
CA turnover rate (ng/g wet tissue/hr) 
Vehicle 
control 17.21+3.01 31.54+2.98 18.59+ 1. 93 34.49+4.31 38.11 +2.17 122.78+14.72 
50 mg/kg 11. 76+1.56 19.33+3.01a 19.39+2.41 42.06+6.07 38.16+5.00 110.97+4.49 
100 mg/kg 13.07+2.33 22.67+3.60b 16.37+3.10 44.69+ 11.01 36.59+2.57 136.95+8.47 
CA rate constant of efflux (hr-1) 
Vehicle 
control 0.133+0.021 0.177+0.019 0.146+0.015 0.158+0.020 0.180+0.012 0.274+0.027 
50 mg/kg 0.096+0.012 0.114+0.013c 0.149+0.015 0.173+0.021 0.160+0.018 0.246+0.007 
100 mg/kg 0.103+0.016 0.123+0.017d 0.139+0.025 0.188+0.040 0.145+0.00ge 0.249+0.013 
CA turnover time (hr) 
Vehicle 
control 8.95+1.40 6.22+0.78 7.61+0.73 7.46+1.03 5.69+0.38 3.83+0.38 
50 mg/kg 11. 79+ 1. 57 9.52+ 1.01 f 7.35+0.74 6.76+0.91 7.12+ 1.44 4.08+0.11 
100 mg/kg 14.98+5.00 10.64+2.219 10.10+2.30 7.64+1.58 7.10+0.57h 4.01+0.22 
PND = postnatal day; NE = norepinephrine; DA = dopamine. Values are means ~ SEM of 6 to 10 determin-
ations in each group at each age. 
Significantly differen~ from control by student t-tests: at(14) = 2;9, P<O.Ol; bt(16) = 2.0, P<0.05; 
Ct (14).=h2•81 P~O.Ol; t(16) = 2.1, P<0.05; et(ll) = 2.4, P<0.025; t(14) = 2.7, P<O.Ol; 9t(16) = 1.9, 
P<0.05, t(l) - 2.0, P<0.05. 
TABLE 21: NOREPINEPHRINE AND DOPAMINE CONTENT (NG/G WET TISSUE) IN THE THALAMUS-HYPOTHALAMUS 
REGION OF THE RAT AT VARIOUS AGES FOLLOWING PRENATAL EXPOSURE TO VEHICLE OR 
2,4-D/2,4-S-T MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
PND 7 PND 9 PND 15 
Group 
Vehicle 
Control 
50 mg/kg 
100 mg/kg 
NE DA NE 
330.5+32.8 229.3+35.7 309.3+69.8 
269.4+15.3 lS0.9+20.4a 274.5+30.8 
286.64+15.2 141.S+22.6b 269.9+8.7 
Values are means + SEM for 4 to 6 rats/group. 
PND = postnatal day 
DA 
90.2+13.9 
100.2+27.1 
113.4+24.0 
NE 
432.8+31.4 
461. 3+22.9 
435.8+49.3 
Significantly different from the appropriate control values by student t-tests: 
at(10) = 1.9, P<O.OS. 
bt(9) = 2.0, P<0.05. 
DA 
143.3+13.3 
184.2+20.0 
317.4+104.2 
TABLE 22: NOREPINEPHRINE AND DOPAMINE CONTENT (NG/G WET TISSUE) IN THE PONS-MEDULLA REGION OF 
THE RAT AT VARIOUS AGES FOLLOWING PRENATAL EXPOSURE TO VEHICLE OR 2,4-D/2,4,5-T 
MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
PND 7 PND 9 PND 15 
Group 
Vehicle 
Control 
50 mg/kg 
100 mg/kg 
NE 
326.8+11.9 
334.4+5.1 
312.1+18.1 
DA 
57.2+7.5 
30.9+8.3a 
29.6+4.6c 
NE 
310.0+22.8 
313.1+17.8 
262.6+31.6 
DA NE 
138.3+31.9 596.6+20.2 
161.9+55.9 559.2+27.8 
37.5+14.4d 521.4+17.5 
Values are means + SEM of 4 to 6 rats/group (except c, N=3). 
PND = postnatal day 
Significantly different from the appropriate control values by student t-tests: 
at(6) = 2.4, P<0.05. 
bt(7) = 2.2, P<0.05. 
Ct(5) = 2.9, P<0.025. 
dt(10) = 2.9, P<0.01. 
DA 
80.4+21. 2 
39.Q+4.0b 
85.1+24.2 
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cantly reduced below control values by 73% on PND 15 (Table 22). In 
contrast, the NE levels in the thalamus-hypothalamus and pons-medulla 
were not significantly affected by treatment on PND 7, 9 or 15 (Table 
21 and 22). 
The levels of DA in the olfactory bulb of pups in the 50 and 100 
mg/kg groups were significantly lower than control values by 34 and 
27%, respectively, on PND 9 (Figure 19). The NE levels in the olfac-
tory lobes of pups in the treated groups were not significantly 
affected, although they tended to decrease below control values (Fig-
ure 19). 
Serotonin and 5-HIAA contents: The levels of 5-HT in the thalamus-
hypothalamus were not significantly affected in the treated groups on 
PND 9 and 25 (Figure 20). On PND 9, the levels of 5-HT in the pons-
medulla of pups in the treated groups tended to decrease non-signifi-
cantly below control values (Figure 20). On PND 25, however, 5-HT 
levels in the pons-medulla of the 100 mg/kg group significantly 
decreased by 14% below control values (Figure 20). 
The levels of 5-HIAA, which is an indirect indicator of 5-HT turn-
over, were not significantly affected in the thalamus-hypothalamus of 
the treated groups on PND 9 (Figure 21). On PND 25, however, 5-HIAA 
levels in the thalamus-hypothalamus of the treated groups signifi-
cantly decreased below control values by 9 and 16%, respectively, (Fig-
ure 21). Also on PND 25, 5-HIAA levels in the pons-medulla of the 100 
mg/kg group significantly decreased by 22% below control values (Fig-
ure 21). 
FIGURE 19: CATECHOLAMINE LEVELS IN THE OLFACTORY BULB OF 9-DAY 
OLD RATS PRENATALLY EXPOSED TO VEHICLE OR 2,4-0/ 
2,4,5-T MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
VALUES ARE MEANS ~ SEM FOR 5 TO 6 RATS/GROUP. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS BY STUDENT 
T-TESTS: 
a t(9) = 2.2, P<0.05. 
b t(10) = 1.9, P<0.05. 
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FIGURE 20: SEROTONIN LEVELS IN THE THALAMUS-HYPOTHALAMUS AND 
PONS-MEDULLA OF RATS PRENATALLY EXPOSED TO VEHICLE 
OR 2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 6 TO 
15. 
VALUES ARE MEANS ~ SEM FOR 4 TO 6 RATS/GROUP. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS BY STUDENT 
T-TEST: tea) = 2.2, P<0.05. 
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FIGURE 21: 5-HYDROXYINDOLEACETIC ACID LEVELS IN THE THALAMUS-
HYPOTHALAMUS AND PONS-MEDULLA OF RATS PRENATALLY 
EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON 
GESTATIONAL DAYS 6 TO 15. 
VALUES ARE MEANS ~ SEM FOR 4 TO 6 RATS/GROUP. 
* SIGNIFICANTLY DIFFERENT FROM CONTROLS BY STUDENT 
T-TESTS: 
a t(9) = 2.1, P<0.05. 
b t(9) = 2.2, P <0.05. 
e t(8) = 2.5, P<0.025. 
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V. DISCUSSION 
The data generated by this study have demonstrated that prenatal 
exposure to non-teratogenic levels of a 2,4-D/2,4,5-T mixture altered 
behavioral and neurochemical development in the overtly normally devel-
oping rats. 
Maternal Observation and Progeny Maturation 
The individual doses of 2,4-D and 2,4,5-T in the 1:1 mixture used 
in this study have been shown to be non-teratogenic in rats (Schwetz 
et al., 1971; Sparschu et al., 1971; Hansen et al., 1971; Emerson et 
al., 1971; Khera and McKinley, 1972). The doses of 2,4-D/ 2,4,5-T 
mixture (50, 100, and 125 mg/kg) tested in the present study did not 
appear to be teratogenic to the rats. This conclusion was based only 
on the external examination of the neonates on PND 1 for gross malfor-
mation. 
The low dose of the 2,4-D/2,4,5-T mixture (50 mg/kg) did not 
appear to adversely affect the pregnant animals since their weight 
gains and gestational lengths were not significantly different from 
control values (Figure 11 and Table 13). However, the pregnant rats 
treated with 100 or 125 mg/kg significantly gained less weight during 
pregnancy, although their gestational lengths were not affected. Addi-
tional toxic effects associated with the 100 and 125 mg/kg treatment 
regimens were reduced litter size on PND 1, and increased neonatal 
mortality only in the 125 mg/kg group. A few pups from the control 
and other treatment groups were also found dead on PND 1. However, 
this phenomenon is expected in rodents. Higher doses of phenoxy herbi-
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cides, however, are known to be embryotoxic in rats (Schwetz et al., 
1971; Hansen et al., 1971; Sparschu et al., 1971; Khera and McKinley, 
1972; Hayes, 1982). Inspite of these effects on PNO 1, there was no 
indication that prenatal exposure of rats to the 2,4-0/2,4,5-T mix-
tures was toxic or lethal to the neonates or during their postnatal 
development. Exposure to the 2,4-0/2,4,5-T mixtures did not signifi-
cantly affect neonatal birth weights, sex ratios, the rate of progeny 
maturation and growth up to PNO 60. However, the 125 mg/kg of 2,4-0/ 
2,4,5-T mixture produced a slight but significant reduction (3%) in 
offspring body weights on PNO 60. Thus, based on gestational and 
birth records, postnatal maturation and weight gains, the 125 mg/kg of 
2,4-0/2,4,5-T can be considered to be the maximum non-observable 
effect level (NOEL) for offspring survival, growth and maturation. 
The NOEL for the pregnant rat, however, was estimated to be less than 
100 mg/kg. 
Postnatal Behavior 
The important features of this study were that prenatal exposure 
of rats to 1:1 mixture of 2,4-0/2,4,5-T markedly delayed and altered 
neurobehavioral and neurochemical development during the preweaning 
and early postweaning periods. The early preweaning (PNO 1-11) devel-
opment of surface righting reflex and swimming performance as well as 
late preweaning (PNO 12-21) development of negative geotaxis as 45° 
angle were significantly delayed in all the treated groups. In addi-
tion, the 100 and 125 mg/kg groups manifested delayed responses to 
early preweaning tests of negative geotaxis at 25° angle and olfactory 
discrimination of home-nest odor. It was interesting that only the 
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male offspring in the 125 mg/kg group manifested significantly higher 
running wheel activity counts following amphetamine challenges on PND 
22 and 23 (Figure 18a). It is unclear why a behavioral sex difference 
was observed. Hormonal sex differences were probably partly respons-
ible for the effect (Blizard et al., 1975; Robbins, 1977; Concannon 
and Schechter, 1981; Rodriguez et al., 1984). The low dose of 2,4-D/ 
2,4,5-T (50 mg/kg) did not significantly affect the responses to the 
tests of olfactory discrimination, negative geotaxis at 25° (males 
only), and running wheel activity. It is difficult to ascribe the 
differences between the low and high treatment groups solely to dose-
related phenomenon, since there were no clear cut dose-response rela-
tionships at certain chronological periods of behavioral testings 
(e.g. surface righting reflex and negative geotaxis). Similarly other 
investigators have not observed dose-response relationships with dif-
ferent behavioral tests in rats and mice following prenatal exposure 
to 2,4,5-T and other behavioral teratogens (Vorhees, 1974; Vorhees et 
al., 1979b; Kellogg et al., 1980; Vorhees and Butcher, 1982; Vorhees 
et al., 1983a; Crampton and Rogers, 1983). A probable explanation for 
this phenomenon was that the sensitive zone, in the dose-response 
curve, for producing the desired effects was so narrow that relatively 
wide variation in doses readily fell outside the sensitive zone and 
markedly changed the nature of the behavioral responses (Vorhees, 
1974; Vorhees and Butcher, 1982). Overlapping in the dose-response 
curve is known to easily occur in behavioral teratology (Vorhees and 
Butcher, 1982). One may rapidly move from a no-effect level of a com-
pound to a behavioral teratogenic dose, and then to a malforming dose 
(Vorhees, 1974; Vorhees and Butcher, 1982). Another explanation for 
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this phenomenon could be that the behavioral tests applied were not 
sensitive enough to differentiate at a singl~ end-point between doses 
in a narrow range. Thus testing and retesting procedure over a rela-
tively long period of time might make it easier to demonstrate dose-
response relationships (Vorhees and Butcher, 1982; Vorhees et al, 
1983b). It is a truism that developing behavioral tests of greater 
sensitivity will be useful in overcoming this problem. In the present 
study repeating the behavioral tests (e.g. surface righting reflex, 
swimming and olfactory discrimination) in an ontogenic chronological 
manner revealed trends towards dose-response relationships. 
The concept that a neurophysiological or pharmacological chal-
lenge to the eNS may overcome compensatory mechanisms and thereby 
reveal otherwise hidden neurotoxicant-induced damage has been ade-
quately tested (Dyer and Boyes, 1983; MacPhail et al., 1983; Zenick, 
1983). d-Amphetamine was used as a pharmacological challenge to un-
mask subtle behavioral effects following prenatal exposure of rats to 
methylmercury (Hughes and Sparber, 1977). In the present study 
d-amphetamine challenges were used to unmask possible subtle behavior-
al abnormalities in the running wheel activities of the 2,4-D/2,4,5-T 
~ utero exposed rats, since there was no treatment effect on the run-
ning wheel activities on PND 21 and 60 (Figure 18 a,b and Table 15). 
Following the pharmacological challenges, however, only the early 
weaned male rats in the 125 mg/kg group significantly manifested 
higher activity counts than the controls on PND 22 and 23 (Figure 18a). 
Amphetamine is known to produce hyperactivity in animals by ,increasing 
the release of NE and DA into the synaptic clefts and inhibiting their 
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reuptake by presynaptic catecholaminergic neurons (Glowinski, 1970; 
Aulakh et al., 1982). Hyperactivity in an open-field behavior was 
observed in rats prenatally exposed to 2,4,5-T (Sjoden and Soderberg, 
1972; 1975; 1978; Crampton and Rogers, 1983). In one study, male rats 
prenatally exposed to 2,4,5-T were significantly hyperactive whereas 
the females were not (Sjoden and Soderberg, 1972). This sex-related 
effect, however, could not be reproduced in subsequent experiments 
(Sjoden and Soderberg, 1975). In the present study, the sex-related 
effect of 2,4-D/2,4,5-T treatment was seen only in the running wheel 
activity behavior of males in the 125 mg/kg group on PND 22 and 23, 
. 
and in the negative geotaxis (at 25°) of females in the 50 mg/kg group 
on PND 9. 
The behavioral effects associated with ~ utero exposure to the 
2,4-D/2,4,5-T mixture in this study demonstrated the mixture to be a 
behavioral teratogen in the rat. This conclusion is similar to 
reports concerning the behavioral teratogenicity of 2,4,5-T in rats 
(Sjoden and Soderberg, 1972; 1975; 1978; Crampton and Rogers, 1983) 
and chickens (Sanderson and Rogers, 1981). 
The behavioral tests used in this study are well established tech-
niques utilized in evaluating CNS function and neuromuscular responses 
during postnatal development of rodents (Salas and Schapiro, 1970; 
Schapiro et al., 1970; Gregory and Pfaff, 1971; Altman and Sudarshan, 
1975; Cornwell-Jones and Sobrian, 1977; Vorhees et al., 1979a,b; Adams 
and Buelke-Sam, 1981; Comer and Norton, 1982). Measurement of the 
ontogeny of swimming behavior is commonly used for the evaluation of 
CNS and neuromotor development (Salas and Schapiro, 1970; Schapiro et 
al., 1970; Vorhees et al., 1979a,b.). Surface righting reflex and 
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negative geotaxis measure the development of the vestibular function 
and the associated integrative motor responses to space orientation 
(Altman and Sudarshan, 1975; Jensh, 1980). The olfactory discrimina-
tion test measures nest seeking response mediated by the olfactory 
system (Gregory and Pfaff, 1971; Cornwell-Jones and Sobrian, 1977). 
The running wheel activity measures the general locomotor activity of 
the animal (Adams and Buelke-Sam, 1981). Thus, the postnatal behav-
ioral changes in the 2,4-0/2,4,5-T ~ utero exposed rats indicated 
possible alterations in more than one functional neuronal mechanism. 
It is important, therefore, that in animal toxicity testing with pos-
sible application to' human risk assessment, a behavioral test battery 
be included in teratology and reproduction testing. A single behav-
ioral test is inadequate since different neurotoxicants may produce 
different behavioral teratology profile within the chosen test system. 
Neurochemistry 
To explore possible neurological consequences of 2,4-0/2,4,5-T 
exposure in the rats, we examined different neurochemical develop-
mental indices of the brain. It has been shown that neurochemical 
changes are possibly the mechanisms responsible for neurobehavioral 
responses in the absence of morphological changes (St. Orner, 1971; 
Jason and Kellogg, 1981; Lucchi et al., 1983; Hong et al., 1983; 1984; 
Nelson et al., 1984) 
Protein and nucleic acids: Examination of regional brain protein, ONA 
and RNA contents, or protein:ONA and RNA:ONA ratios during postnatal 
development did not reveal generalized gross deficiencies in the 
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treated groups. However, the RNA level in the neocortex of the 125 
mg/kg group was significantly reduced below control values by 8% on 
PND 22 (Table 17), but a 6% reduction in the RNA/DNA ratio was not 
significant. Also on PND 22, protein:DNA ratios in the thalamus-hypo-
thalamus of the 50 and 125 mg/kg were significantly below control 
values by 9 and 17%, respectively (Table 18). From these findings, 
however, it is difficult to assess the cellular events that might have 
contributed to the significant changes in RNA contents and protein:DNA 
ratios. The cellular concentration of RNA, however, is a useful index 
of the rate of protein synthesis (Jacob and Monod, 1961; Geel and 
Timiras, 1967; Mahler, 1981; Benjamins and McKhann, 1981; Dunlop et 
al., 1984). Protein:DNA ratio is an indicant of cell size (Benjamins 
and McKhann, 1981). Because the chronological sampling of regional 
brain tissue was limited and no general trend was discernible it is 
not possible to state with any certainty that cellular growth or vol-
ume in the neocortex and thalamus-hypothalamus were affected by the 
2,4-D/2,4,5-T treatments. It is also possible that in the affected 
brain regions there were shifts in the neuronal cell type. For ex-
ample, glial outgrowth might well lead to a reduction in the overall 
RNA or protein/cell levels (Wasterlain and Plum, 1973). However, DNA 
levels, which indicate cellularity (Gombos et al., 1980; Benjamins and 
McKhann, 1981), were not affected by the phenoxy herbicides treatment 
(Table 17). 
Data such as quantitative regional cell counts, neuronal to glial 
ratios, and ornithine decarboxylase activity (the rate limiting enzyme 
involved in the biosynthesis of polyamines and cellular growth) would 
possibly allow an assessment of the type of cellular events that might 
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occur in the brain (Wasterlain and Plum, 1973; Slotkin, 1979; Russell, 
1980; Benjamins and McKhann, 1981). 
Glutamate and GABA: Glutamate and GABA are important putative excita-
tory and inhibitory neurotransmitters, respectively (Cooper et al., 
1982). Both are found in high concentrations in the brain (Cooper et 
al., 1982). About 20 to 50% of the synapses in the brain are 
GABAergic (Reinis and Goldman, 1982; Guidotti et al., 1983). Gluta-
mate and GABA have intimate biochemical relationships to tricarboxylic 
acid cycle in the brain as well as synaptic connections to the cate-
cholaminergic system (Roberts and Anderson, 1979; Bartholini, 1980; 
McGeer and McGeer, 1981; Donzanti and Uretsky, 1983). Both glutamate 
and GABA have been reported to be involved in locomotor behavior of 
rodents (Pycock and Horton, 1976; Anden et al., 1979; Donzanti and 
Uretsky, 1983). With the exception of a significant reduction in glu-
tamate levels in the cerebrum and cerebellum of the treated groups on 
PND 1, there was no significant alteration in glutamate or GABA levels 
in any of the brain areas examined on PND 15 and 22 (Table 16). The 
significance of this finding on PND 1 or its relation to the early 
behavioral changes are not known. The hypothesis that glutamate 
enhances locomotion activity through release of dopamine has been 
recently supported by ~ vivo studies (Donzanti and Uretsky, 1983). 
However, further mammalian studies are needed involving the glutamate 
and GAB A systems and their interaction with the biogenic amine systems 
during the early preweaning period following prenatal exposure to the 
phenoxy herbicides. 
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Catecholamines: Prenatal exposure of rats to the 2,4-D/2,4,5-T mix-
ture altered early preweaned development of DA turnover in the whole 
brain as well as DA levels in the thalamus-hypothalamus, pons-medulla 
and olfactory bulb. The significant effect of the 100 mg/kg dose on 
NE rate constant of efflux and turnover time on PND 15 indicated a 
delayed NE effect which was dose dependent. A similar but non-signifi-
cant effect was observed in the 50 mg/kg group. These effects and the 
associated significant elevations of the steady-state whole brain NE 
levels in both treated groups as well as the DA levels in the ·100 
mg/kg group possibly reflected a decrease in CA metabolism. 
The development of the catecholaminergic system in the rat has 
been implicated as a mediator in the ontogeny of different behavioral 
responses, such as swimming, arousal, feeding, olfaction and locomotor 
activity (Campbell and Mabry, 1973; Mabry and Campbell, 1977; Tam~sy 
et al., 1981; Adams and Buelke-Sam, 1981; Barrett et al., 1982; 
Cornwell-Jones and Bollers, 1983; Fuller, 1983; Bannon and Roth, 
1983). 
Tam~sy and coworkers (1981) reported that the increased availabil-
ity of DA in the brain of developing rat was essential for motor coor-
dination during swimming behavior. Injected l-dopa improved the coor-
dination of limb movements and the ability to keep the head out of the 
water (PND 3,5,7) more efficiently than untreated pups (Tam~sy et al., 
1981). Similarly apomorphine (a dopaminergic agonist) and l-dopa 
reversed swimming impairment of aged rats (Marshall and Berrios, 1979). 
It appears, therefore, that during swimming, which is a stressful situ-
ation, there is a high demand for the CA by the brain (Sudo, 1983; 
Knorr et al., 1984). The importance of the interaction of the nor ad-
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renergic and dopaminergic neuronal mechanisms appeared to be slight 
since l-dopa, which is known to increase brain DA and NE, failed to 
influence swimming behavior when postsynaptic DA receptors were 
blocked by preinjection of haloperidol (Tam~sy et al., 1981). In the 
present study, swimming performance was significantly delayed on PND 7 
(Figure 17). This delay was extended to PND 9 in the highest treat-
ment group. It is possible that the delayed DA turnover on PND 3 and 
decreased levels of DA in the pons-medulla and thalamus-hypothalamus 
on PND 7 contributed to the adverse effects observed on the swimming 
performance in the phenoxy herbicide exposed rats. 
It is difficult, however, to conclude a definite cause and effect 
relation from the present findings because swimming behavior might be 
more closely related to subtle changes of catecholaminergic system in 
discrete brain regions than to changes observed in the whole brain or 
grossly dissected areas. There is also the possibility that swimming 
is also modulated by other neurotransmitters and/or hormones (Schapiro 
et al., 1970; Bhagat and Wheeler, 1973; Anderson and Schanberg, 1975; 
Skerritt et al., 1981), since GABA and glutamate, present in brain 
structures primarily involved in the regulation of locomotor behavior 
activity, modulate the release of DA (Mogenson et al., 1980a,b; 
Donzanti and Uretsky, 1983). 
The possible correlative effects of the neurochemical changes and 
the delayed development of surface righting reflex and negative geo-
taxis in treated groups cannot be established from the present find-
ings. This is in part because the current understanding of these 
reflex behaviors and the underlying neurochemical functions are incom-
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plete (Adams and Buelke-Sam, 1981). However, Jason and coworkers 
(1981) reported that prenatal exposure of rats to imipramine (an anti-
depressant) altered surface righting and negative geotaxis reflexes on 
PND 7 and 9, and reduced the number of cortical beta adrenergic 
receptors on PND 14 and 30. Further characterizations of these reflex 
behavioral responses in relation to different neurochemical systems 
are needed. 
The olfactory bulb in the mammalian brain is known to be rich in 
neuroactive substances which are important for the discrimination of 
odor signals (Halasz and Shepherd, 1983). Although the role of CA in 
facilitating the olfactory sense is not fully defined, most data sup-
ported a modulatory role of these amines in the olfactory function in 
rodents (Sobrian and Cornwell-Jones, 1977; Marasco et al., 1979; 
Cornwell-Jones, 1981; Barrett et al., 1982; Cornwell-Jones and 
Bollers, 1983; Halasz and Shepherd, 1983). Gregory and Pfaff (1971) 
demonstrated that rat pups, when presented with a choice involving 
home-nest odor, prefer the side of home-nest bedding. This preference 
was selectively attenuated by neonatal treatment with 6-hydroxydopa-
mine (Sobrian and Cornwell-Jones, 1977; Marasco et al., 1979). When 
6-hydroxydopamine was given intraventricularly or intracerebrally it 
produced an extensive depletion of brain NE and DA and a degeneration 
of the central NE and DA-containing neurons (Cooper et al., 1982). 
Marasco and coworkers (1979) reported that rat pups injected with 
6-hydroxydopamine had reduced NE levels in the olfactory bulb thus 
implicating NE in the ontogeny of olfaction. It was unfortunate that 
tissue DA levels were below assay sensitivity and could not be meas-
ured. In the present study, DA levels in the olfactory bulb of the 50 
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and 100 mg/kg groups were significantly reduced on PND 9 (Figure 19). 
In the treated groups, the NE levels were not significantly affected 
although they tended to decrease (13% and 26% for the 50 and 100 mg/kg 
groups, respectively). However, olfactory discrimination response was 
significantly delayed in the 100 and 125 mg/kg groups but not in the 
50 mg/kg group (Figure 16). Current data attest to the rich diversity 
of neuroactive substances (transmitters and modulators) within olfac-
tory bulb neurons (Hal§sl and Shepherd, 1983). It was quite possible 
that in the lowest treatment group (50 mg/kg) the reduction in CA 
levels was incapable of adversely affecting the neurochemical mechan-
isms involved in olfaction. In contrast, in the high treatment 
groups, in addition to reduction in the CA content the many neurotrans-
mitters and neuromodulators within the complex synaptic circuits in 
the olfactory bulb were probably unable to bring about a homeostatic 
response to prevent a delayed response to the olfactory discrimination 
test. 
Serotonin and 5-HIAA: Serotonin is highly involved in brain struc-
tures responsible for the maintenance of sleep-wakefullness and loco-
motor activity regulation (Graham-Smith, 1971; Jacobs, 1976; Gerson 
and Baldessarini, 1980; Olson and Morgan, 1982). The metabolite of 
serotonin, 5-HIAA was used as an indirect indicator of 5-HT turnover 
in the CNS (Curlon, 1981; Reinhard and Roth, 1982; Reinhard et al., 
1983). The significant reductions in the levels of 5-HT and 5-HIAA in 
the thalamus-hypothalamus and pons-medulla of the treated groups on 
PND 25 possibly reflect a decreased 5-HT turnover. The levels of 5-HT 
and 5-HIAA were not affected on PNO 9. It is possible that 2,4-0/ 
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2,4,5-T treatment produced a later effect on the serotonergic system. 
This would be consistent with the findings of Sjoden and Soderberg 
(1978) that prenatal exposure of rats to 2,4,5-T resulted in a 
decreased brain 5-HT level on PNO 60. However, brain tryptophan and 
5-HIAA levels were not significantly affected (Sjoden and Soderberg, 
1978). Thus, the inability of the investigators to detect differences 
in brain 5-HIAA levels was probably due to the diluting effect of 
using the whole brain rather than discrete areas for neurochemical 
analysis. In the present study discrete brain areas were assayed for 
5-HT and 5-HIAA. 
Possible Mechanisms of Action 
A major characteristic of embryonic-fetal development is the 
existence of critical periods of development (Vorhees and Butcher, 
1982; Williams, 1982). The cellular changes and activity during these 
periods are dynamic, in that minor induced modifications in the intra-
uterine biophase and cellular environment by exogenous chemicals can 
lead to congenital defects. These defects may range from embryo lethal-
ity and anatomical defects to a large variety of more subtle morpholog-
ical, biochemical and functional abnormalities. The phenoxy herbi-
cides 2,4-0 and 2,4,5-T readily cross the placental barrier and dis-
tribute into various fetal organ tissues including the brain 
(Lindquist and Ullberg, 1971; Fang et al., 1973; Oencker, 1976; 
Courtneyet al., 1977; Koshakji et al., 1979). It is possible that 
phenoxy herbicides can induce a wide spectrum of teratogenic effects 
(structural and functional abnormalities) which would be both dose and 
exposure-time dependent. Thus, subtle biochemical abnormalities could 
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be manifested during ontogenesis as behavioral and functional abnormal-
ities. 
The exact mechanisms by which the phenoxy herbicides produce tera-
togenic, behavioral and neurochemical effects in the exposed animals 
are not known. Lindquist and Ullberg (1971) suggested that the terato-
genic action of 2,4-D and 2,4,5-T might result from interference with 
embryonic nutrition because of the selective uptake of the herbicides 
in the yolk sac placenta. However, a single injection of 2,4,5-T on 
day 13 of gestation can cause cleft palate in the fetal mouse · (Neubert 
and Dillmann, 1972). At that stage the main nutritional role of the 
o yolk sac placenta ts over (Bage et al., 1973). It is less likely, 
therefore, that inhibition of the embryonic nutrition is the cause of 
the teratogenic effects of the phenoxy herbicides or the behavioral 
effects at sub-teratogenic levels. 
Because the phenoxy herbicides attain high concentrations in the 
fetal tissues during the organogenesis (Lindquist and Ullberg, 1971; 
Fang et al., 1973; Dencker, 1976; Courtney et al., 1977; Koshakji et 
al., 1979), it is tempting to believe that 2,4-D and 2,4,5-T act 
directly on the fetal tissues. Such an action would affect cellular 
growth and organogesis of which palatal closure is the most sensitive 
(Dencker, 1976; Pratt, 1983). Kolberg and coworkers (1970) reported 
that 2,4-D inhibited the ~ vitro growth and multiplication of Earle's 
L cells (mouse fibroblasts) in the culture medium. This effect was 
reversible upon removal of 2,4-D from the medium. Cellular growth 
retardation and teratogenicity by the phenoxy herbicides may be due to 
direct influence of the compounds on fetal cellular development. 
Lower non-teratogenic doses of the phenoxy herbicides can be expected 
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to produce behavioral and neurochemical abnormalities rather than 
severe anatomical defects. 
It is also possible that the behavioral and neurochemical effects 
seen in the present study were secondary events due to primary changes 
in other neuronal dynamics. Thyroid hormones are not necessary for 
fetal growth but they are critical for maturation and growth during 
postnatal development (Patel et al., 1980; D'Ercole and Underwood, 
1981). Perinatal thyroxine enhances the developmental processes in 
the rat brain, whereas corticosteroid retards them (Schapiro et al., 
1970; Balazs et al., 1975; Anderson and Schanberg, 1975; Patel et al., 
1980). As a result hypothyroidism has been reported to delay develop-
ment of brain biogenic amine systems (Rastogi et al., 1976; Lengvari 
et al., 1980). Chemically thyroidectemized neonatal rats were hypo-
active (Rastogi et al., 1976). Recently Comer and Norton (1982) 
reported that methimazole (antithyroid) administration to pregnant 
rats from gestational days 17 to PND 10 resulted in hypothyroid prog-
eny that manifested delays in the acquisition of surface righting 
reflex, auditory startle response, time of eye opening and decreased 
exploratory activity. A deficit was also observed in reflex-response 
test for motor development. It was of interest to note that in the 
present study early neurobehavioral (surface righting reflex, swim-
ming, negative geotaxis and olfactory discrimination) and neurochem-
ical (DA turnover and the levels of DA and glutamate) development were 
altered in the 2,4-D/2,4,5-T exposed rats. It seems possible to con-
clude that thyroid function in the herbicide-mixture exposed progeny 
was depressed. In support of the proposed mechanism Sjoden and 
Soderberg (1978) reported that prenatal exposure of rats to 2,4,5-T 
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resulted in an initial increase in thyroid activity at birth, followed 
by a rapid fall in thyroid activity (hypothyroidism) during postnatal 
development. Further studies are needed to test these hypotheses and 
to establish the levels of thyroid activity and its relation to brain 
development in neonatal rats following prenatal exposure to 2,4-D/ 
2,4,5-T. 
Changes in maternal behavior and the direct effects of the treat-
ments on the nutritional status of the progeny might have contributed 
to the adverse behavioral and neurochemical effects observed. 
With regards to possible changes in maternal behavior, Sjoden and 
Soderberg (1975) used a crOSS-fostering design for postnatal rearing 
of rats exposed ~ utero to 2,4,5-T, and observed that the adverse 
behavioral effects persisted regardless of maternal rearing condition. 
In the present study, pups were reared by their biologic mothers and 
it is unlikely that maternal rearing conditions significantly affected 
progeny behavior. 
The nutritional status of the developing progeny is important 
because it is well documented that adverse behavioral and neurochem-
ical effects appeared in the progeny of mothers malnourished during 
pregnancy (Winick, 1976; Morgan and Naismith, 1982; Sparber and 
Litchblau, 1983; Wainwright and Russell, 1983; Crnic, 1983). Salas 
(1972) reported that malnutrition adversely affected the development 
of swimming behavior in rats. Neurochemical alterations in the brains 
of undernourished rat pups included a generalized decrease in brain 
nucleic acids, protein, NE, and DA as well as other neurotransmitters 
(Winick, 1976; Vitiello et al., 1980; Morgan and Naismith, 1982; 
Sparber and Lichtblau, 1983; Crnic, 1983). 
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In the present study, with the exception of a 3% reduction in the 
body weights of the 125 mg/kg group on PNO 60, there were no signifi-
cant treatment effects on postnatal weight gains (Figure 12). Also, 
generalized deficits were not seen in brain protein, RNA:ONA and pro-
tein:ONA ratios. Furthermore, a single oral dose of 2,4,5-T which was 
unlikely to produce malnutrition in the ~ utero exposed progeny was 
found to be a behavioral teratogen in rats (Sjoden and SOderberg,1972; 
1975; 1978; Crampton and Rogers, 1983). Thus it was unlikely that 
treatment induced malnutrition occurred in the present study and con-
tributed to the behavioral and neurochemical abnormalities. 
Several studies have indicated that phenoxy herbicides were 
excreted in small quantities in the milk (Fang et al., 1973; Leng, 
1977). In the present study, the last treatment was on gestational 
day 15, thus allowing a nonmedicated period of 6 to 8 days before 
parturition. This period seems to be sufficient for almost complete 
excretion of the 2,4-0/2,4,5-T mixture from body (Leng, 1977; Gehring 
and Betso, 1978). It was estimated that almost complete recovery of 
the administered 2,4-0 and 2,4,5-T occurred in the urine of treated 
rats within 4 to 6 days after dosing (Leng, 1977; Gehring and Betso, 
1978). Furthermore, pregnancy in rats did not alter the rate of 
2,4,5-T elimination from body (Fang et al., 1973). It is, therefore, 
unlikely that in the present study 2,4-0/2,4,5-T passed through the 
milk to the suckling pups in sufficient quantities to induce the 
adverse behavioral and neurochemical effects seen during postnatal 
development. 
The behavioral effects examined in this study indicated that 
there were no severe functional deficits. However, there were delays 
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in the maturational development of behavior and neurochemistry. The 
observed subtle neurotoxic effects on the swimming performance and 
olfactory discrimination (at doses below 125 mg/kg) did not appear to 
be permanent. Delayed swimming performance, for example, appeared 
only during the early preweaning period of rapid brain development. 
It is possible as the brain acquired adult characteristics other neuro-
chemical and neurohormonal compensatory mechanisms or recovery from 
inhibition masked the manifestation of the subtle behavioral effects 
of the phenoxy herbicide. It is well documented that in the adult 
brain interaction between striatal dopaminergic, cholinergic and 
GABAergic neurons is the most important factor in the regulation of 
spontaneous motor function (Bartholini, 1980). 
The nature of the behavioral and neurochemical findings clearly 
indicated the inappropriateness of some preweaning behavioral measure-
ments (swimming performance and olfactory discrimination) as post-
weaning tests for subtle phenoxy herbicides toxicity. The open-field 
test which measures emotional reactivity and exploratory activity has 
proven to be an appropriate test in postweaned rats (PND 35 to 90) 
prenatally exposed to 2,4,5-T (Sjoden and Soderberg, 1972; 1975; 1978; 
Crampton and Rogers, 1983). It is obvious that to study the effects 
of prenatal exposure of 2,4-0/2,4,5-T mixture in the postweaned adult 
rat appropriate behavioral tests must be applied (Vorhees et al., 
1979a,b; Sparber and Lichtblau, 1983). 
Inspite of the inappropriateness of direct extrapolation of ani-
mal data to human, the findings in this study imply a possible risk to 
children prenatally exposed to no observable effect levels of phenoxy 
herbicides or other environmental pollutants. 
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TABLE 1: WEIGHT GAIN (% OF DAY 0) OF PREGNANT RATS TREATED BY GAVAGE 
WITH VEHICLE OR 2,4-D/2,4,5~T MIXTURE 
ON GESTATIONAL DAYS 6 TO 15. 
Gestation day Vehicle Control 50m/kg 100 mg/kg 125 mg/kg 
6 10.8+0.4 11.0+0.7 10.4+0.6 12.0+0.8 
7 11.3+0.6 11.4+0.7 9.9+0.7 11. 7+0.8 
8 12.7+0.6 12.4+0.8 11.1+0.6 11.7+0.9 
-
9 14.3+0.5 13.9+0.8 12.4+0.7 12.9+0.9 
. 
10 16.1+0.7 15.5+0.9 14.2+0.8 14.1+0.9 
11 18.1+0.7 17.3+1.0 15.7+0.8* 15.6+0.8* 
12 19.2+0.8 18.5+ 1. 0 16.7+0.8* 16.0+0.9* 
13 21.2+0.8 20.3+1.1 18.5+0.9* 16.6+ 1.1 * 
14 23.3+0.8 22.0+1.2 20.5+0.9* 18.4+ 1.1 * 
15 26.0+0.9 24.4+ 1.2 22.1 +1.1* 19.8+ 1.1 * 
16 29.7+1.1 27.5+1.3 25.8+1.1* 20.8+1.2* 
20 53.1+1.5 52.0+1. 7 47.1 +1. 7* 41.1 +2.0* 
-
Values are means ~ SEMfor 16 to 36 rats/group. 
* Significantly different from controls, by ANOVA [F(3,107) = 116, 
P<O.OOOl] and LSD, P<0.05. 
TABLE 2: POSTNATAL BODY WEIGHTS (G) OF RATS PRENATALLY EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON 
ON GESTATIONAL DAYS 6 TO 15. 
Postnatal Vehicle Control 50 mg/kg 100 mg/kg 125 mg/kg 
Day M F M F M F M F 
4 11. 7+0.2 11.3+0.2 11.3+0.2 11.4+0.2 11. 3+0.1 . 11.0+0.1 11.2+0.3 10.7+0.3 
7 17.7+0.2 17.1+0.3 17 .1+0.3 16.9+0.3 17.2+0.2 16.B+0.2 16.B+0.4 16.6+0.2 
14 34.1+0.4 32.7+0.4 33.1+0.6 32.3+0.5 33.3+0.5 31.5+0.6 33.2+0.9 31.7+0.7 
21 56.4+1.0 53.5+0.9 56.0+1.1 51.1+3.1 54.9+0.9 52.3+0.B 52.9+1.6 51.5+1.4 
30 112.5+ 1. 5 100.1+1.4a 112.6+1.4 100.5+1.3a 111. 5+1.6 99.1 + 1. 2a lOB.5+2.5 9B.B+1.Ba 
60 332.4+5.1 216.4+3.2a 33B.3+4.7 21B.0+3.7a 334.5+4.0 216.0+3.1a 322.B+5.9b 209.1+4.3a,b 
N = 12 to 26 litters/sex group. M = male, F = female. 
a Significantly different from male littermates by ANOVA [F(1,14B) = 1051, P<O.OOOl] and LSD, P<0.05. 
b Significantly different from controls by ANOVA [F(3,14B) = 3.B, P<0.02] and LSD, P<0.05. 
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TABLE 3: PERCENT OF PUPS/LITTER RIGHTING IN 2 SECONDS FOLLOWING 
PRENATAL EXPOSURE TO VEHICLE OR 2,4-0/2,4,5-T MIXTURE 
ON GESTATIONAL DAYS 6 TO 15. 
Postnatal day Vehicle control 50 mg/kg 100 mg/kg 125 mg/kg 
2 . 5.4+2.2 10.9+3.8 6.3+3.6 0.0* 
3 34.9+6.0 27.9+5.2 17.2+6.3* 23.1+4.4 
4 64.1+5.4 42.6+8.2* 45.3+6.5* 48.1+8.7* 
-
5 88.0+3.5 69.1+4.6* 65.6+7.5* 63.5+7.8* 
Values are means + SEM for 13 to 23 litters/group. 
* Significantly dTfferent from controls, by ANOVA [F(3,65) = 8.8, 
P<O.OOOl] and Mann-Whitney U-test, P<0.05. 
TABLE 4: NEGATIVE GEOTAXIS RESPONSE AT 25 0 ANGLE (LATENCY IN SECONDS TO COMPLETE 1800 TURN) IN RATS 
PRENATALLY EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
Postnatal Vehicle Control 50 mg/kg 100 mg/kg 125 mg/kg 
Day M F M F M F M F 
7 25.3+3.1 24.7+2.7 29.5+4.4 25.7+2.4 25.5+3.3 26.4+3.4 29.6+2.2 23.5+3.0 
8 23.2+3.0 21. 9+2. 5 23.2+3.1 26.6+3.2 27.2+3.4 24.8+3.7 25.9+2.1 27.1+3.5 
9 17.2+1.8 17.1+2.3 21.1+2.7 23.3+3.0* 23.0+3.5 23.6+3.0* 24.6+2.9* 21.7+2.6 
10 13.3+1.6 14.7+1.3 15.7+2.1 15.0+2.0 20.7+3.1* 20.7+2.9* 20.1 +1. 9* 20.7+1.9* 
11 11.7+1.4 13.9+2.9 12.7+2.4 13.6+2.3 26.8+6.6* 10.8+1.3 19.5+3.6* 16.0+3.3 
Values are means + SEM for 13 to 23 litters/sex/group. 
M = male, F = female. 
* Significantly different from controls by ANOVA [F(3,129) = 6.9, P<0.0002] and LSD, P <0.05. 
TABLE 5: NEGATIVE GEOTAXIS RESPONSE AT 45 0 ANGLE (LATENCY IN SECONDS TO COMPLETE 1800 TURN) IN RATS 
PRENATALLY EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 6 TO 15. 
Postnatal Vehicle Control 50 mg/kg 100 mg/kg 125 mg/kg 
Day M F M F M F M F 
15 5.9+0.4 6.7+0.5 7.3+0.6* 5.9+0.4 6.7+0.5 6.9+0.7 7.9+1.0* 8.1+0.9* 
16 5.8+0.5 5.0+0.3 6.3,:!:0,5 7.1+0.6* 6.4+0.5 7.1+0.8* 5.6+0.5 5.7+0.5 
17 4.9+0.3 5.0+0.3 6.1+0.4* 6.5+0.5* 6.0+0.5* 6.3+0.5* 6.7+0.6* 6.3+0.7* 
Values are means + SEM for 13 to 23 litters/sex/group. 
M = male, F = female. 
* Significantly different from controls by ANOVA [F(3,126) = 6.9, P<0.0002] and LSD, P<0.05. 
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TABLE 6: OLFACTORY DISCRIMINATION RESPONSE (LATENCY IN SECONDS TO 
ENTER THE SIDE OF HOME-NEST BEDDING) IN RATS PRENATALLY 
EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE 
Group 
Vehicle 
Control 
50 mg/kg 
100 mg/kg 
125 mg/kg 
ON GESTATIONAL DAYS 6 TO 15. 
PND 9 PND 10 PND 11 
M F M F M F 
51.1+4.8 50.4+6.5 52.2+5.3 44.9+4.4 40.0+4.9 38.7+4.1 
55.8+5.2 50.1+5.8 52.9+6.9 49.0+6.5 34.1+4.1 44.2+5.8 
- , 
63.9~5.4* 67.6~6.3* 52.0+6.3 58.0+7.0 
74.4~5.6* 87.9~7.3* 82.0~6.8* 58.3~6.8 
50.4+6.6 37.6+5.3 
58.1+7.5* 59.3+9.7* 
- -
Values are means + SEM for 13 to 23 litters/sex/group. 
M = male, F = female. 
* Significantly different from controls by ANOVA [F(3,128) = 22.6, 
P<O.OOOl] and LSD, P<0.05. 
TABLE 7: SWIMMING ANGLE SCORES OF RATS PRENATALLY EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE 
ON GESTATIONAL DAYS 6 TO 15. 
Postnatal Vehicle Control 50 mg/kg 100 mg/kg 125 mg/kg 
Day M F M F M F M F 
7 1.50+0.15 1.50+0.18 0.82+0.16* 0.85+0.19* 1.06+0.17* 0.88+0.18* 0.35+0.14* 0.42+0.18* 
9 2.50+0.11 2.57+0.12 2.32+0.14 2.50+0.13 2.47+0.15 2.44+0.12 1.88+0.19* 1.96+0.11* 
11 2.91+0.10 2.95+0.08 2.76+0.09 2.79+0.09 2.72+0.12 2.91+0.15 2.65+0.16 2.71+0.11 
13 3.76+0.08 3.73+0.09 3.50+0.11 3.62+0.11 3.59+0.10 3.63+0.10 3.77+0.13 3.58+0.13 
15 4.0 3.98+0.02 3.97+0.03 4.0 3.97+0.03 4.0 4.0 4.0 
21 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 
Values are means + SEM for 13 to 23 litters/sex/group. 
M = male, F = female. 
* Significantly different from controls by ANOVA [F(3,129) = 24.8, P<O.OOOl] and Mann-Whitney U-test, 
P<0.05. 
152 
TABLE 8: RUNNING WHEEL ACTIVITY (ROTATIONS/18.5 HR) OF RATS PRENATALLY 
EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE 
ON GESTATIONAL DAYS 6 TO 15. 
PND 21 PND 22a PND 23b 
Group M F M F M F 
Vehicle 
Control 1429+140 1542+190 2259+318 2043+226 2030+157 2163+293 
50 mg/kg 1459+226 1648+325 2360+404 2790+595 2428+363 2605+489 
100 mg/kg 1310+176 1712+242 2236+233 2351+388 1929+289 2121+276 
125 mg/kg 1927+175 1946+361 3283+504* 2589+570 2891+397* 2067+328 
- - - -
Values are means + SEM for 10 to 18 rats/sex/group. 
PND = postnatal day, M = male, F = female. 
d-Amphetamine challenges (a = 0.5 mg/kg, b = 1.5 mg/kg, i.p.) 
* Significantly different from controls by ANOVA [F(3,100) = 8.4, P<O.OOOl] 
and LSD, P<0.05. 
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TABLE 9: CATECHOLAMINE LEVELS (NG/G WET TISSUE) IN THE OLFACTORY 
BULB OF 9-DAY OLD RATS PRENATALLY EXPOSED TO VEHICLE OR 
2,4-D/2,4,5-T MIXTURE ON GESTATIONAL DAYS 6 to 15. 
Group 
Vehicle Control 
50 mg/kg 
100 mg/kg 
Norepinephrine 
109.9+7.2 
95.2+8.8 
81.8+17.4 
Values are means + SEM for 5 to 6 rats/group. 
Significantly different from controls by student t-tests: 
at(9) = 2.2, P<0.05. 
bt(10) = 1.9, P<0.05. 
Dopamine 
30.6+3.8 
20.2+2.3a 
22.4+1.7b 
TABLE 10: SEROTONIN (5-HT) AND 5-HYDROXYINDOLEACETIC ACID (5-HIAA) LEVELS (NG/G WET TISSUE) IN BRAIN 
REGIONS OF RATS PRENATALLY EXPOSED TO VEHICLE OR 2,4-D/2,4,5-T MIXTURE 
ON GESTATIONAL DAYS 6 TO 15. 
Neurotransmitter PND 
5-HT 9 
25 
o mg/kg 
595.5+86.3 
816.2+40.2 
Pons-medulla 
50 mg/kg 
528.4+46.5 
867.4+21.4 
Thalamus-hypothalamus 
100 mg/kg o mg/kg 50 mg/kg 100 mg/kg 
437.0+61.7 199.5+5.1 190.9+27.4 258.0+36.0 
699.1+34.2a 492.6+26.5 502.4+64.3 492.5+21.4 
5-HIAA 9 1516.9+253.0 1653.5+184.2 1085.8+132.7 271.0+15.1 285.5+29.8 285.7+17.8 
25 1049.0+88.3 1028.5+64.0 
Values are means + SEM for 4 to 6 rats/group. 
PND = postnatal day. 
813.0+34.9b 825.4+33.2 754.3+29.0c 691.0+48.1d 
Signficantly different from controls by student t-tests: 
at(8) = 2.2, P<0.05. 
bt(8) = 2.5, P<0.025. 
Ct(9) = 2.1, P<0.05. 
dt(9) = 2.2, P<0.05. 
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